Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

What changed

The record changes every day, and every change is shown here with its reason. Nothing is deleted: an entry withdrawn from publication keeps its history, and a corrected entry keeps the value it had before.

16,551entries added in the last 30 days
6,871outcomes recorded
5,519outcomes confirmed
1,152withdrawn as outside the methodology

Why the totals move

Three things happen every day. New press releases are read and new commitments added. Past deadlines are checked and outcomes recorded. And every published entry is screened, once, against the scope rules: an entry that turns out to be a financial forecast, too vague to check, or a repeat of another entry is withdrawn from publication with its reason. So the number of commitments on record can fall on a day when the record became more accurate.

The complete history of every change is available as a file: keptindex-changes.csv (1,519 changes).

27 Oct 2026

  • 236added
  • 78outcomes recorded
  • 1withdrawn from publication
  • 5corrected
Withdrawn: Outside the methodology's scope (1)
  • Chiasma, Inc.: Present five accepted late-breaker abstracts from the MPOWERED Phase 3 study at ENDO 2021 · outside the methodology's scope (event: Presenting abstracts at a medical conference (ENDO 2021) is a conference participation, not an operational milestone.)
Corrections
  • Akebia Therapeutics, Inc.: deadline corrected from 2021-05-15 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Atrion Corp.: deadline corrected from 2021-06-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • CPS Technologies Corp.: deadline corrected from 2021-06-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • FRP Holdings, Inc.: deadline corrected from 2021-09-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • NextCure, Inc.: deadline corrected from 2021-06-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

26 Oct 2026

  • 887added
  • 198outcomes recorded
  • 7confirmed (1 by tie-break)
  • 10corrected
Corrections
  • ADC Therapeutics S.A.: deadline corrected from 2021-06-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Alpha Healthcare Acquisition Corp.: deadline corrected from 2021-06-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • BTCS Inc.: deadline corrected from 2021-06-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Castor Maritime Inc.: deadline corrected from 2021-03-31 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Castor Maritime Inc.: deadline corrected from 2021-04-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Castor Maritime Inc.: deadline corrected from 2021-03-31 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Cheesecake Factory Inc.: deadline corrected from 2022-02-17 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Diodes Inc. /Del/: deadline corrected from 2021-06-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • First MID Bancshares, Inc.: deadline corrected from 2021-06-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Ionis Pharmaceuticals Inc.: deadline corrected from 2021-06-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

25 Oct 2026

  • 1,382added
  • 638outcomes recorded
  • 750confirmed (42 by tie-break)
  • 46withdrawn from publication
  • 11corrected
Withdrawn: Financial forecast, not an operational deliverable (20), Too vague to check (16), Outside the methodology's scope (7), Depends on a third party, not the company (3)
  • Activision Blizzard: Release seasonal events and live operations for Candy Crush Saga · outside the methodology's scope (vague: Routine live operations and seasonal events are ongoing business activities, not a specific project completion.)
  • Alaska Air Group (ALK): Return to 100% of 2019 capacity · outside the methodology's scope (vague: Returning to a capacity percentage is a financial/performance target, not a specific operational milestone.)
  • Alaska Air Group (ALK): Take delivery of eight aircraft under capacity agreement · outside the methodology's scope (third_party: This is a capacity agreement with a third party (SkyWest), and the delivery is dependent on the partner's operations.)
  • Alexandria Real Estate Equities (ARE): Achieve initial occupancy at the One Rogers Street and One Charles Park redevelopment project · outside the methodology's scope (financial: Occupancy targets are generally considered performance/financial metrics rather than discrete operational milestones.)
  • Aptiv (APTV): Reduce CO2e emissions · outside the methodology's scope (financial: This is a performance target (emissions reduction percentage) rather than a specific operational project.)
  • Bolt Biotherapeutics, Inc. (BOLT): Close the private placement financing · outside the methodology's scope (financial: Closing a private placement financing is a financial transaction, not an operational commitment.)
  • Cadeler A/S (CDLR): Extend the offer period for the voluntary share exchange offer · outside the methodology's scope (other: This is an administrative extension of an offer period, not a core operational commitment.)
  • Casey's (CASY): Add approximately 200 units · outside the methodology's scope (vague: Adding units is a general growth target/plan rather than a specific project.)
  • Celanese (CE): Implement debottleneck and process efficiency improvements at European powders facilities · outside the methodology's scope (vague: The commitment to 'implement debottleneck and process efficiency improvements' is an ongoing operational improvement without a clear, checkable end-state.)
  • CenterPoint Energy (CNP): Roll out the company's Net-Zero ESG plan · outside the methodology's scope (vague: The rollout of an ESG plan is a broad corporate initiative without a specific, checkable operational milestone.)
  • Constellation Brands (STZ): Return product inventories to normal levels · outside the methodology's scope (vague: Returning inventory to 'normal levels' is a vague operational goal without a specific, checkable metric.)
  • CRH plc (CRH): Achieve the 2030 carbon emissions reduction target · outside the methodology's scope (financial: This is a target for carbon emissions reduction, which is a performance/sustainability target rather than a specific operational project.)
  • Crown Castle (CCI): Deploy a similar number of small cell nodes · outside the methodology's scope (vague: Deploying a 'similar number' of nodes is a vague operational target, not a specific, checkable project completion.)
  • Electronic Arts: Grant no special equity awards to any NEOs in fiscal 2022 · outside the methodology's scope (financial: This is a compensation policy/financial governance matter, not an operational commitment.)
  • Exelon (EXC): Reduce company-wide operations-driven emissions by 15% · outside the methodology's scope (financial: This is a performance target (percentage reduction of emissions).)
  • Federal Realty Investment Trust (FRT): Reduce landlord-controlled electric usage and greenhouse gas emissions · outside the methodology's scope (financial: This is a performance/reduction target.)
  • Freeport-McMoRan (FCX): Reach 100% of targeted average production for Grasberg underground mines · outside the methodology's scope (financial: This is a production target/performance metric rather than a specific operational project completion.)
  • Healthpeak Properties (DOC): Achieve occupancy of the remaining 30,000 square feet at 75 Hayden · outside the methodology's scope (financial: Occupancy targets are financial/performance metrics.)
  • Host Hotels & Resorts (HST): Complete 85% of the Marriott transformational capital program · outside the methodology's scope (vague: Completing a percentage of a capital program is a financial/progress metric rather than a specific operational milestone.)
  • Kansas City Southern: Improve customer service in the second half of 2021 · outside the methodology's scope (vague: Improving customer service is a vague, non-checkable operational goal.)
  • Lennar (LEN): Grow community count by approximately 10% year-over-year · outside the methodology's scope (financial: This is a growth target/metric, not a specific operational project.)
  • Marathon Petroleum (MPC): Achieve production capacity of 48,000 barrels per day of renewable diesel at the Martinez facility · outside the methodology's scope (financial: Production capacity targets are performance metrics.)
  • Maxlinear, Inc. (MXL): Settle bonus awards for the 2026 performance period in common stock · outside the methodology's scope (financial: Settling bonus awards in stock is a financial/compensation matter.)
  • Mohawk Industries (MHK): Expand operations in Mexico · outside the methodology's scope (vague: Expanding operations is a vague, ongoing process without a specific checkable end point.)
  • Mohawk Industries (MHK): Introduce new products with enhanced features and lower production complexity · outside the methodology's scope (vague: Introducing new products is a general business activity, not a specific, checkable operational milestone.)
  • Mohawk Industries (MHK): Increase production capacity via capital investments · outside the methodology's scope (vague: Increasing production capacity via capital investments is a general plan, not a specific, checkable operational milestone.)
  • NiSource (NI): Commence third-party Safety Management System validation for accreditation · outside the methodology's scope (third_party: The commitment is to commence third-party validation, which relies on the third party's schedule and process.)
  • Norwegian Cruise Line Holdings (NCLH): Operate 40% of fleet capacity · outside the methodology's scope (financial: This is a capacity/performance target.)
  • Norwegian Cruise Line Holdings (NCLH): Operate 75% of fleet capacity · outside the methodology's scope (financial: This is a capacity/performance target.)
  • Penn Entertainment (PENN): Operate in at least 10 states · outside the methodology's scope (financial: This is a market share/geographic footprint target.)
  • Perspective Therapeutics, Inc. (CATX): Present additional clinical trial data at the NANETS 2026 Multidisciplinary NET Medical Symposium · outside the methodology's scope (event: Presenting data at a conference is a routine corporate event.)
  • Perspective Therapeutics, Inc. (CATX): Present additional clinical trial data at the EORTC-NCI-AACR (ENA) Symposium · outside the methodology's scope (event: Presenting data at a conference is a routine corporate event.)
  • Pg&E Corp (PCG): Obtain the 2025 Safety Certificate · outside the methodology's scope (third_party: Obtaining a safety certificate is a regulatory approval process.)
  • Phillips 66 (PSX): Establish greenhouse gas emission reduction targets · outside the methodology's scope (vague: Establishing targets is a vague corporate process without a concrete operational output.)
  • Pioneer Natural Resources: Publish 2021 Sustainability Report · outside the methodology's scope (other: Publishing a sustainability report is a routine corporate communication, not an operational commitment.)
  • Quest Diagnostics Inc. (DGX): Launch a laboratory test panel for purchase via the Apple Health app · outside the methodology's scope (already_done: The text implies the capability is already announced/available.)
  • RingCentral, Inc. (RNG): Make Agentic Voice AI generally available · outside the methodology's scope (vague: The phrase 'later this year' is not a specific, checkable end point for a general availability launch.)
  • Royal Caribbean Group (RCL): Operate 36 ships across its brands · outside the methodology's scope (financial: This is a capacity/operational metric target rather than a specific project completion.)
  • Royal Caribbean Group (RCL): Have 80% of capacity in service · outside the methodology's scope (financial: This is a capacity/operational metric target.)
  • Sealed Air: Design or advance 100% of packaging materials to be recyclable or reusable · outside the methodology's scope (vague: The commitment to 'design or advance' is too broad and lacks a clear, checkable operational end point.)
  • Take-Two Interactive (TTWO): Conclude the NBA 2K League season with the Finals · outside the methodology's scope (event: This is a scheduled event (a season conclusion/finals).)
  • Valero Energy (VLO): Reduce and offset Refining GHG emissions by 63% · outside the methodology's scope (vague: This is an aspirational environmental target rather than a specific operational project.)
  • Ventas (VTR): Complete property dispositions · outside the methodology's scope (financial: This is a financial target regarding capital recycling/disposition value rather than a specific operational project.)
  • Vici Properties (VICI): Extend the expiration date of the Exchange Offers · outside the methodology's scope (other: This is an administrative extension of an offer period, not a core operational commitment.)
  • Wynn Resorts (WYNN): Launch enhanced product features for WynnBET · outside the methodology's scope (vague: The commitment to 'expand market position' is vague and lacks a checkable end point.)
  • Zions Bancorporation (ZION): Fully implement Lean Portfolio Management · outside the methodology's scope (vague: Implementing 'Lean Portfolio Management' is an internal process change without a clear, checkable operational end-state.)
Corrections
  • BHP Group Ltd: deadline corrected from 2027-06-30 to 2027-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Castor Maritime Inc.: deadline corrected from 2021-04-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Inhibrx, Inc.: deadline corrected from 2021-09-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Insu Acquisition Corp. II: deadline corrected from 2022-01-13 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Inter Parfums Inc.: deadline corrected from 2021-06-21 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • LMP Automotive Holdings, Inc.: deadline corrected from 2021-04-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Murphy USA Inc.: outcome changed from Met to Late · the evidence dates delivery after the deadline (integrity rule F1)
  • Replimune Group, Inc.: outcome changed from Met to Late · the evidence dates delivery after the deadline (integrity rule F1)
  • Rigel Pharmaceuticals Inc.: deadline corrected from 2021-04-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Sorrento Therapeutics, Inc.: deadline corrected from 2022-03-31 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • U.S. Gold Corp.: deadline corrected from 2021-09-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

24 Oct 2026

  • 1,442added
  • 534outcomes recorded
  • 127confirmed (26 by tie-break)
  • 50withdrawn from publication
  • 14corrected
Withdrawn: Financial forecast, not an operational deliverable (16), Outside the methodology's scope (14), Too vague to check (11), Depends on a third party, not the company (7), Accounting or internal process (2)
  • Activision Blizzard: Release new mobile Warcraft content · outside the methodology's scope (vague: The commitment to release 'new mobile Warcraft content' is too vague and lacks a specific, checkable end point.)
  • Activision Blizzard: Complete the acquisition by Microsoft · outside the methodology's scope (being_acquired: The company is the one being acquired.)
  • AES Corporation (AES): Exit coal generation by year-end 2025, subject to necessary approvals · outside the methodology's scope (third_party: The commitment is explicitly subject to necessary regulatory approvals.)
  • Airbnb (ABNB): Announce the Airbnb 2021 Winter Release · outside the methodology's scope (event: This is a corporate event/announcement.)
  • Akzo Nobel N.V. (AKZOY): Close the proposed merger with Axalta · outside the methodology's scope (third_party: The commitment is subject to regulatory approvals, making it contingent on a third party.)
  • Alaska Air Group (ALK): Retire all Q400 aircraft · outside the methodology's scope (already_done: The commitment date (2023) has passed.)
  • Albemarle Corporation (ALB): Double nameplate capacity · outside the methodology's scope (financial: Doubling nameplate capacity is a performance/growth target rather than a specific construction project.)
  • BranchOut Food Inc. (BOF): Produce 60,000 to 70,000 kilograms of product per month · outside the methodology's scope (financial: This is a production volume target, which functions as a performance/financial target.)
  • Carnival Corporation (CCL): Remove three additional ships from the fleet · outside the methodology's scope (already_done: The commitment date (2022) has passed.)
  • Casey's (CASY): Add approximately 225 units during fiscal 2022 · outside the methodology's scope (already_done: The commitment date (2022) has passed.)
  • Ceridian: Make new products and features available to customers · outside the methodology's scope (vague: General statement about making products available without a specific, checkable milestone.)
  • CF Industries (CF): Return gross ammonia production to historical levels · outside the methodology's scope (financial: Returning production to historical levels is a performance target.)
  • Consolidated Edison (ED): Achieve 21,000 electric vehicle plug installations under make-ready program · outside the methodology's scope (vague: Targets for installations under a program are often treated as performance goals rather than specific construction projects.)
  • Coterra Energy: Average four completion crews during the fourth quarter of 2021 · outside the methodology's scope (vague: A plan to average a number of crews is an operational plan/forecast rather than a specific project completion.)
  • Crown Castle (CCI): Achieve carbon neutrality in Scope 1 and 2 emissions · outside the methodology's scope (vague: Carbon neutrality goals are often aspirational targets rather than specific, checkable operational milestones.)
  • DTE Energy (DTE): Renew 200 miles of gas main under the main renewal program · outside the methodology's scope (already_done: The commitment date (2022) has passed.)
  • DTE Energy (DTE): Renew 200 miles of gas mains in 2022 · outside the methodology's scope (already_done: The commitment date (2022) has passed.)
  • DTE Energy (DTE): Continue main renewal program with a target of 200 miles of gas main renewed · outside the methodology's scope (vague: This is a general operational program with a target metric rather than a specific, checkable completion event.)
  • Enphase Energy (ENPH): Release new software features to improve the installer experience · outside the methodology's scope (vague: Vague commitment to release features with no specific checkable end point or scope.)
  • Equinix (EQIX): Close the acquisition of four data centers from Entel · outside the methodology's scope (already_done: The commitment date (2022) has passed.)
  • Etsy (ETSY): Increase seller transaction fee to 6.5% · outside the methodology's scope (financial: Changing a transaction fee is a financial/pricing decision, not an operational project.)
  • General Mills (GIS): Close the sale of European dough businesses to Cérélia · outside the methodology's scope (third_party: The commitment is subject to competition approvals (third-party), and it is a divestiture/sale rather than an operational expansion.)
  • Healthpeak Properties (DOC): Achieve initial occupancy at the Vantage life science development · outside the methodology's scope (financial: Occupancy is a financial/performance metric, not a specific operational milestone like construction completion.)
  • Helus Pharma Inc. (HELP): File a New Drug Application for HLP003 with the FDA · outside the methodology's scope (third_party: Filing an NDA is a regulatory submission process, often excluded as it is the first step of a third-party review.)
  • Hormel Foods (HRL): Implement the new five-year raw material supply agreement · outside the methodology's scope (other: Implementing a supply agreement is a contractual/administrative step, not a direct operational output like building or launching.)
  • Iamgold Corp. (IAG): Announce an updated Côté Gold mine plan and Mineral Reserve estimate · outside the methodology's scope (other: Publishing a plan or estimate is a corporate reporting/planning activity, not an operational commitment.)
  • Iron Mountain (IRM): Deliver over 30 MW of data center capacity for the full year · outside the methodology's scope (financial: This is framed as a capacity target/performance metric for the year.)
  • Mid-America Apartment Communities (MAA): Stabilize the Novel Midtown apartment community · outside the methodology's scope (financial: Stabilization is a financial/performance metric for real estate assets.)
  • Mid-America Apartment Communities (MAA): Establish a dedicated ESG department · outside the methodology's scope (already_done: The commitment date (2022) has passed.)
  • Mid-America Apartment Communities (MAA): Perform smart home installations · outside the methodology's scope (vague: Enhancing revenue is a financial goal, and 'smart home installations' is a broad initiative without a specific, checkable completion milestone.)
  • Mosaic Company (The) (MOS): Revert mined volumes to normal levels · outside the methodology's scope (vague: Reverting to 'normal levels' is a vague operational target without a specific, checkable end point.)
  • Mosaic Company (The) (MOS): Reach normalized operating rates in the phosphates segment · outside the methodology's scope (vague: Reaching 'normalized levels' is a vague operational target without a specific, checkable end point.)
  • Mosaic Company (The) (MOS): Exceed recent historical levels of total potash production · outside the methodology's scope (financial: Production volume targets are generally considered performance/financial targets.)
  • NiSource (NI): Achieve 50% reduction in methane emissions from gas mains and services · outside the methodology's scope (vague: Sustainability targets like emission reductions are generally considered aspirational goals rather than specific, checkable operational milestones.)
  • Norwegian Cruise Line Holdings (NCLH): Operate approximately 85% of berth capacity · outside the methodology's scope (financial: This is a capacity utilization target rather than a specific operational milestone.)
  • People's United Financial: Complete the systems conversion · outside the methodology's scope (already_done: The commitment date (2022) has passed.)
  • Philip Morris International Inc. (PM): Transition the majority of the ZYN flagship portfolio to 20-pouch cans · outside the methodology's scope (vague: The text provided does not explicitly state a commitment to transition the portfolio, it discusses marketing and investment plans.)
  • Pinnacle West Capital (PNW): Begin seasonal operating schedule at Four Corners, subject to necessary approvals · outside the methodology's scope (third_party: The commitment is explicitly subject to necessary regulatory approvals, making it contingent on a third party.)
  • Pioneer Natural Resources: Place 475 to 505 wells on production · outside the methodology's scope (financial: Production targets (number of wells) are operational performance targets, not specific construction projects.)
  • Pioneer Natural Resources: Place approximately 50 15,000-foot lateral wells on production · outside the methodology's scope (financial: Production targets (number of wells) are operational performance targets, not specific construction projects.)
  • Pioneer Natural Resources: Reduce freshwater use in completion operations to less than 25% · outside the methodology's scope (financial: This is a sustainability/efficiency target rather than a specific operational project completion.)
  • RLI Corp. (RLI): Implement the approved rate filing · outside the methodology's scope (third_party: Implementing a rate filing is typically subject to regulatory approval and is a routine administrative action.)
  • Sherwin-Williams (SHW): Implement a 12% price increase in The Americas Group · outside the methodology's scope (financial: Price increases are financial/pricing actions, not operational commitments.)
  • Valero Energy (VLO): Begin startup activities for the carbon sequestration project · outside the methodology's scope (third_party: The project is described as belonging to BlackRock and Navigator, not the issuing company.)
  • Vici Properties (VICI): Complete the exchange offer expiration · outside the methodology's scope (accounting: This is an administrative/accounting step related to an exchange offer, not an operational commitment.)
  • Vici Properties (VICI): Contribute interest in VICI LP to New VICI Operating Company · outside the methodology's scope (accounting: This is an internal corporate restructuring/accounting step, not an operational commitment.)
  • Warner Bros. Discovery (WBD): Complete the merger with WarnerMedia and related transactions · outside the methodology's scope (already_done: The commitment date (2022) has passed.)
  • Welltower (WELL): Complete asset dispositions · outside the methodology's scope (financial: Asset dispositions are financial transactions, not operational commitments.)
  • Wynn Resorts (WYNN): Make financial information available to noteholders and investors · outside the methodology's scope (accounting: Providing financial information is a routine accounting/reporting task.)
  • Xilinx: Close the acquisition of Xilinx by Advanced Micro Devices · outside the methodology's scope (being_acquired: The company is the one being acquired.)
Corrections
  • Beam Therapeutics Inc.: outcome changed from Met to Late · the evidence dates delivery after the deadline (integrity rule F1)
  • Beam Therapeutics Inc.: outcome changed from Met to Late · the evidence dates delivery after the deadline (integrity rule F1)
  • Coca-Cola Enterprises: deadline corrected from 2016-06-30 to 2016-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Coca-Cola Enterprises: deadline corrected from 2016-06-30 to 2016-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Frontier Communications: deadline corrected from 2017-08-01 to 2017-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Newfield Exploration: deadline corrected from 2018-03-31 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Noble Energy: deadline corrected from 2017-09-30 to 2017-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Noble Energy: deadline corrected from 2017-09-30 to 2017-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Replimune Group, Inc.: outcome changed from Met to Late · the evidence dates delivery after the deadline (integrity rule F1)
  • Reynolds American: deadline corrected from 2016-06-30 to 2016-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Viacom: deadline corrected from 2018-09-30 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • XL Group: deadline corrected from 2018-01-31 to 2017-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • XL Group: deadline corrected from 2018-01-31 to 2017-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • XL Group: deadline corrected from 2019-01-31 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

23 Oct 2026

  • 576added
  • 218outcomes recorded
  • 303confirmed (39 by tie-break)
  • 3withdrawn from publication
Withdrawn: Outside the methodology's scope (3)
  • Cimarex Energy: Maintain an operated rig count of five rigs · outside the methodology's scope under the current rules
  • Cimarex Energy: Maintain three drilling rigs in the Delaware Basin · outside the methodology's scope under the current rules
  • Range Resources (RRC): Maintain an average of three rigs running · outside the methodology's scope under the current rules

22 Oct 2026

  • 65added
  • 14outcomes recorded
  • 88confirmed (88 by tie-break)
  • 3corrected
Corrections
  • Alexion Pharmaceuticals: deadline corrected from 2020-09-30 to 2020-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Nov: deadline corrected from 2018-09-30 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Nov: deadline corrected from 2019-09-30 to 2019-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

21 Oct 2026

  • 805added
  • 408outcomes recorded
  • 413confirmed (65 by tie-break)
  • 42withdrawn from publication
  • 66corrected
Withdrawn: Financial forecast, not an operational deliverable (16), Too vague to check (14), Outside the methodology's scope (8), Depends on a third party, not the company (4)
  • Abiomed: Complete the acquisition of Abiomed · outside the methodology's scope (being_acquired: The company is the target of the acquisition, not the acquirer.)
  • Abiomed: Reintroduce the Abiomed Breethe Oxy-1 system to the U.S. market · outside the methodology's scope (third_party: The commitment is contingent on receiving regulatory clearance.)
  • AES Corporation (AES): Complete all projects in the renewable energy backlog · outside the methodology's scope (vague: The commitment to complete 'all projects' in a backlog is too broad and lacks a specific, checkable end point for individual projects.)
  • Alaska Air Group, Inc. (ALK): Expand Seattle's nonstop international network to 15 routes · outside the methodology's scope (vague: This is a strategic plan/goal rather than a specific operational commitment to launch a specific route by a specific date.)
  • Albemarle Corporation (ALB): Close the acquisition of Qinzhou conversion plant · outside the methodology's scope (third_party: The closing of the acquisition is contingent on the regulatory approval process.)
  • American Airlines Group (AAL): Increase premium seating in the fleet by more than 20% · outside the methodology's scope (financial: This is a growth target (percentage increase in seating capacity).)
  • Americas Carmart Inc. (CRMT): Complete technology-related initiatives · outside the methodology's scope (vague: Technology-related initiatives is too broad and lacks a specific, checkable operational outcome.)
  • Anavex Life Sciences Corp. (AVXL): Meet with the FDA to discuss adding pediatric participants to the Phase 3 Rett syndrome study · outside the methodology's scope (third_party: Meeting with the FDA is a regulatory interaction/process.)
  • Carnival Corporation (CCL): Achieve a 30% reduction in unit food waste · outside the methodology's scope (financial: This is a performance target/metric reduction goal.)
  • Catalent: Restore productivity levels at the Bloomington manufacturing facility · outside the methodology's scope (financial: Restoring productivity levels is a performance/financial target rather than a specific operational milestone.)
  • Celanese (CE): Reflect volume and net sales for 70 kt of annual POM offtake in the EM base business · outside the methodology's scope (vague: This describes an accounting/reporting outcome rather than a discrete operational milestone.)
  • CF Industries (CF): Make a final investment decision on constructing the blue ammonia production facility · outside the methodology's scope (other: A final investment decision is a corporate governance/capital allocation decision, not an operational execution task.)
  • Constellation Brands (STZ): Reduce Scope 1 and Scope 2 greenhouse gas emissions · outside the methodology's scope (vague: This is a broad sustainability goal without a specific, checkable operational project.)
  • Constellation Brands (STZ): Restore water withdrawals and improve water accessibility in critical watersheds · outside the methodology's scope (vague: This is a broad sustainability goal without a specific, checkable operational project.)
  • Coterra Energy: Achieve total company flare intensity between 0.118 and 0.131 percent · outside the methodology's scope (financial: This is an emissions intensity target, which functions as a performance/sustainability metric rather than a discrete operational milestone.)
  • Coterra Energy: Achieve methane emissions intensity between 0.033 and 0.038 percent · outside the methodology's scope (financial: This is an emissions intensity target, which functions as a performance/sustainability metric rather than a discrete operational milestone.)
  • Coterra Energy: Achieve greenhouse gas emissions intensity between 5.20 and 5.94 metric tons CO2e per MBoe · outside the methodology's scope (financial: This is an emissions intensity target, which functions as a performance/sustainability metric rather than a discrete operational milestone.)
  • Duke Realty: Close the acquisition of Duke Realty by Prologis · outside the methodology's scope (being_acquired: The company is the one being acquired.)
  • Etsy (ETSY): Extend Star Seller status for Florida sellers · outside the methodology's scope (vague: Extending a status is a policy/programmatic adjustment rather than a specific operational milestone.)
  • Ford Motor Company (F): Sell more than 600,000 electric vehicles in Europe · outside the methodology's scope (financial: This is a sales volume target, which is a financial/performance metric.)
  • Interpublic Group: Close the acquisition of IPG by Omnicom · outside the methodology's scope (being_acquired: The company is the one being acquired.)
  • Interpublic Group: Close the merger transaction with Omnicom · outside the methodology's scope (being_acquired: The company is the one being acquired.)
  • Interpublic Group: Close the acquisition of Interpublic Group · outside the methodology's scope (being_acquired: The company is the one being acquired.)
  • Interpublic Group: Complete strategic restructuring actions · outside the methodology's scope (vague: Strategic restructuring actions is a broad corporate plan without a specific, checkable operational end point.)
  • Interpublic Group: Execute a program of accelerated business transformation to enhance offerings and drive structural expense savings · outside the methodology's scope (vague: Business transformation is a broad, non-specific corporate initiative.)
  • LKQ Corporation (LKQ): Achieve 73% participation in employee engagement survey and engagement score of 76 · outside the methodology's scope (vague: Employee engagement scores are internal metrics, not a concrete operational output.)
  • Marathon Oil: Secure increased exposure to the global LNG market · outside the methodology's scope (vague: Securing exposure to a market is a vague strategic goal rather than a specific operational milestone.)
  • Marathon Oil: Close the acquisition of Marathon Oil Corporation · outside the methodology's scope (being_acquired: The company is the one being acquired.)
  • Mid-America Apartment Communities (MAA): Stabilize two development communities · outside the methodology's scope (financial: Stabilization of development communities is a financial/performance metric related to occupancy and lease-up.)
  • Newell Brands (NWL): Implement the Project Phoenix restructuring program · outside the methodology's scope (vague: Implementing a restructuring program is a broad corporate plan rather than a specific, checkable operational milestone.)
  • Pioneer Natural Resources: Operate an average of 22 to 24 horizontal drilling rigs · outside the methodology's scope (vague: Operating an average number of rigs is an operational plan/ramp-up rather than a specific, checkable end-point event.)
  • Pioneer Natural Resources: Place 490 to 520 wells on production · outside the methodology's scope (financial: This is a production volume target, which is a performance/operational metric rather than a specific project completion.)
  • Pioneer Natural Resources: Close the acquisition of Pioneer Natural Resources · outside the methodology's scope (being_acquired: The company is the one being acquired.)
  • Pioneer Natural Resources: Achieve methane intensity of 0.20% or less · outside the methodology's scope (financial: This is an environmental performance target/metric.)
  • Pioneer Natural Resources: Increase Permian production volume to approximately 2 MOEBD · outside the methodology's scope (financial: This is a production volume target.)
  • PVH (PVH): Record a pre-tax gain from the sale of equity investment in Karl Lagerfeld Holding B.V · outside the methodology's scope (accounting: This is an accounting/financial reporting event.)
  • Rapport Therapeutics, Inc. (RAPP): Hold an End-of-Phase 2 meeting with the FDA regarding RAP-219 · outside the methodology's scope (third_party: An End-of-Phase 2 meeting is a regulatory interaction/approval process.)
  • UDR, Inc. (UDR): Settle new forward equity sale agreements · outside the methodology's scope (financial: Settling equity sale agreements is a financial/capital markets activity.)
  • United Airlines Holdings, Inc. (UAL): Reach 61% Starlink Wi-Fi availability on aircraft · outside the methodology's scope (financial: This is a performance/penetration target (percentage availability).)
  • United Airlines Holdings, Inc. (UAL): Reach 87% Starlink Wi-Fi availability on aircraft · outside the methodology's scope (financial: This is a performance/penetration target (percentage availability).)
  • United Airlines Holdings, Inc. (UAL): Reach fleet-wide Starlink Wi-Fi availability · outside the methodology's scope (financial: This is a performance/penetration target (fleet-wide availability).)
  • Whirlpool Corporation (WHR): Conclude the strategic review of the EMEA business · outside the methodology's scope (vague: A strategic review is an internal process, not a concrete operational output.)
Corrections
  • Aardvark Therapeutics, Inc.: removed 1 restatement(s) about a different project · the restatement names STRENGTH but the original is about ARD-101, HONOR
  • Acadia Pharmaceuticals Inc.: removed 1 restatement(s) about a different project · the restatement names ACP-101, COMPASS, PWS but the original is about ACP-044
  • Aldeyra Therapeutics, Inc.: removed 1 restatement(s) about a different project · the restatement names ADX but the original is about TRANQUILITY, TRANQUILITY-2
  • Aldeyra Therapeutics, Inc.: removed 2 restatement(s) about a different project · the restatement names ADX but the original is about ADX-2191
  • Aldeyra Therapeutics, Inc.: removed 2 restatement(s) about a different project · the restatement names INVIGORATE-2 but the original is about TRANQUILITY-2
  • American Airlines Group: removed 1 restatement(s) about a different project · the restatement names 787-8 but the original is about 787-9, 787-9S
  • American Airlines Group: removed 1 restatement(s) about a different project · the restatement names A321NEO but the original is about A350
  • American Airlines Group: removed 1 restatement(s) about a different project · the restatement names 787-9S but the original is about 787-8, 787-8S
  • American Airlines Group: deadline corrected from 2021-01-01 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Beam Therapeutics Inc.: removed 1 restatement(s) about a different project · the restatement names BEAM-201 but the original is about BEACON, BEAM-101
  • Beam Therapeutics Inc.: removed 1 restatement(s) about a different project · the restatement names AATD but the original is about BEAM-201
  • Beam Therapeutics Inc.: removed 1 restatement(s) about a different project · the restatement names AATD, BEAM-302 but the original is about BEACON
  • Beam Therapeutics Inc.: removed 1 restatement(s) about a different project · the restatement names BEAM-103, ESCAPE but the original is about BEAM-301
  • Boeing Co.: removed 1 restatement(s) about a different project · the restatement names VC-25B but the original is about 777-8, 777-9
  • Capricor Therapeutics, Inc.: removed 1 restatement(s) about a different project · the restatement names HOPE-2 but the original is about HOPE-3
  • Capricor Therapeutics, Inc.: removed 1 restatement(s) about a different project · the restatement names HOPE-2 but the original is about HOPE-3
  • Corcept Therapeutics Inc.: removed 1 restatement(s) about a different project · the restatement names MONARCH but the original is about CATALYST
  • Corcept Therapeutics Inc.: removed 4 restatement(s) about a different project · the restatement names BELLA but the original is about GRADIENT; the restatement names MOMENTUM but the original is about GRADIENT
  • Delta Air Lines: removed 2 restatement(s) about a different project · the restatement names A321NEOS but the original is about A-350, A-350S; the restatement names A321S but the original is about A-350, A-350S
  • Delta Air Lines: removed 1 restatement(s) about a different project · the restatement names MD-90 but the original is about MD-88
  • Disc Medicine, Inc.: removed 1 restatement(s) about a different project · the restatement names DBA but the original is about CKD
  • Disc Medicine, Inc.: removed 2 restatement(s) about a different project · the restatement names CKD but the original is about DISC-0974; the restatement names IBD but the original is about DISC-0974
  • Disc Medicine, Inc.: removed 1 restatement(s) about a different project · the restatement names IBD but the original is about DBA
  • Disc Medicine, Inc.: removed 2 restatement(s) about a different project · the restatement names IBD but the original is about DISC-0974, NDD-CKD; the restatement names RALLY-MF but the original is about DISC-0974, NDD-CKD
  • Disc Medicine, Inc.: removed 1 restatement(s) about a different project · the restatement names SCD but the original is about DISC-3405
  • Disc Medicine, Inc.: removed 1 restatement(s) about a different project · the restatement names IBD but the original is about DISC-0974
  • Disc Medicine, Inc.: removed 1 restatement(s) about a different project · the restatement names RALLY-MF but the original is about APOLLO
  • DTE Energy: removed 1 restatement(s) about a different project · the restatement names NEXUS but the original is about FERC
  • Edison International: removed 1 restatement(s) about a different project · the restatement names SCE, TKM but the original is about CPUC, GRC
  • Edison International: removed 1 restatement(s) about a different project · the restatement names SCE but the original is about CPUC, TKM
  • FirstEnergy: removed 1 restatement(s) about a different project · the restatement names WVPSC but the original is about IRP
  • Fuelcell Energy Inc.: removed 1 restatement(s) about a different project · the restatement names HPPA but the original is about LIPA
  • Gen Digital: removed 1 restatement(s) about a different project · the restatement names DRS but the original is about CREST
  • Huntington Ingalls Industries: outcome changed from Met to Late · the evidence dates delivery after the deadline (integrity rule F1)
  • Huntington Ingalls Industries: outcome changed from kept to late · HII's Ingalls Shipbuilding launched the future USS Jeremiah Denton (DDG 129) destroyer on March 25, 2025, well within the 2025 deadline.
  • Incyte: removed 1 restatement(s) about a different project · the restatement names INCAGN1949, OX40 but the original is about GITR, INCAGN1876
  • LKQ Corporation: deadline corrected from 2024-09-30 to 2024-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Moderna: removed 2 restatement(s) about a different project · the restatement names MRNA-1403 but the original is about MRNA-1647; the restatement names MRNA-4157, PCV but the original is about MRNA-1647
  • Mohawk Industries: deadline corrected from 2018-06-30 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Oneok: removed 4 restatement(s) about a different project · the restatement names 000-BARREL, MB-6 but the original is about MB-4; the restatement names MB-5 but the original is about MB-4; the restatement names ONEOK but the original is about MB-4
  • Organon & Co.: deadline corrected from 2022-03-31 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Prologis: removed 1 restatement(s) about a different project · the restatement names IPT but the original is about DCT
  • Pyxis Oncology, Inc.: removed 1 restatement(s) about a different project · the restatement has no quotation from the source
  • Regeneron Pharmaceuticals: removed 1 restatement(s) about a different project · the restatement names DLBCL but the original is about REGN1979
  • Replimune Group, Inc.: removed 1 restatement(s) about a different project · the restatement names IGNYTE, RP1 but the original is about RP3
  • Replimune Group, Inc.: removed 1 restatement(s) about a different project · the restatement names IGNYTE-3 but the original is about RP1
  • SELLAS Life Sciences Group, Inc.: removed 1 restatement(s) about a different project · the restatement names PTCL, SLS009 but the original is about GFH009
  • Southwest Airlines: removed 6 restatement(s) about a different project · the restatement names 737-8 but the original is about 737-700; the restatement names MAX but the original is about 737-700
  • Southwest Airlines: removed 1 restatement(s) about a different project · the restatement names 737-8 but the original is about 737-800
  • Southwest Airlines: removed 1 restatement(s) about a different project · the restatement names 737-8 but the original is about MAX
  • SVB Financial Group: deadline corrected from 2020-07-25 to 2020-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Take-Two Interactive: removed 1 restatement(s) about a different project · the restatement names 2K18, WWE but the original is about 2K17, NBA
  • Take-Two Interactive: outcome changed from Met to Late · the evidence dates delivery after the deadline (integrity rule F1)
  • Take-Two Interactive: outcome changed from kept to late · Sid Meier's Civilization VII launched worldwide on February 11, 2025, as planned, confirmed by Wikipedia and multiple game reviews.
  • Tesla, Inc.: removed 1 restatement(s) about a different project · the restatement names LFP but the original is about CHRISTI, CORPUS, LITHIUM, PRODUCTION, REFINERY, START
  • Tyra Biosciences, Inc.: removed 1 restatement(s) about a different project · the restatement names SURF302 but the original is about SURF301
  • uniQure N.V.: removed 1 restatement(s) about a different project · the restatement names AMT-162 but the original is about AMT-130
  • uniQure N.V.: removed 1 restatement(s) about a different project · the restatement names ICIEM but the original is about AMT-260
  • United Airlines Holdings: removed 1 restatement(s) about a different project · the restatement names 737-700 but the original is about MAX
  • Valero Energy: removed 1 restatement(s) about a different project · the restatement names MPBD but the original is about BPD

20 Oct 2026

  • 883added
  • 313outcomes recorded
  • 694confirmed (41 by tie-break)
  • 46withdrawn from publication
  • 2corrected
Withdrawn: Too vague to check (20), Financial forecast, not an operational deliverable (14), Outside the methodology's scope (10), Accounting or internal process (1), Depends on a third party, not the company (1)
  • Alexandria Real Estate Equities (ARE): Achieve a waste diversion rate of at least 45% for managed buildings · outside the methodology's scope (vague: Waste diversion rate is a sustainability metric/target rather than a specific operational project or launch.)
  • Ansys: Close the acquisition of Ansys · outside the methodology's scope (being_acquired: Ansys is the company being acquired, so this commitment belongs to the acquirer's record.)
  • Ansys: Reduce scope 1 and scope 2 emissions by 15% · outside the methodology's scope (financial: This is an environmental performance target/goal, not a specific operational project.)
  • Builders FirstSource (BLDR): Set short-, medium-, and long-term Scope 1 and Scope 2 emissions reduction targets · outside the methodology's scope (vague: Setting targets is a planning/administrative activity, not a specific operational output.)
  • BXP, Inc. (BXP): Achieve carbon-neutral operations · outside the methodology's scope (vague: Carbon-neutral operations is a broad, long-term sustainability goal rather than a specific, checkable operational milestone.)
  • Caesars Entertainment (CZR): Complete the capital investment in the Caesars New Orleans property · outside the methodology's scope (vague: Completing a capital investment is a financial/spending activity rather than a specific operational milestone.)
  • Campbell's (CPB): Launch new salsa/picante product · outside the methodology's scope (vague: A 'new launch' in a fiscal year is too vague to be a specific, checkable operational commitment.)
  • Church & Dwight (CHD): Achieve 95% fill rates for most brands · outside the methodology's scope (financial: This is a performance target related to fill rates/inventory metrics.)
  • Coterra Energy: Publish the first Coterra Energy Sustainability Report · outside the methodology's scope (other: Publishing a sustainability report is a routine corporate disclosure/administrative task, not an operational commitment.)
  • Coterra Energy: Publish the 2023 Sustainability Report · outside the methodology's scope (accounting: Publishing a sustainability report is a routine corporate reporting activity.)
  • Coterra Energy: Decide on maintaining the second Marcellus rig · outside the methodology's scope (vague: Making a decision is an internal management process, not a concrete operational output.)
  • Coterra Energy: Operate two Marcellus rigs · outside the methodology's scope (vague: Operating rigs is a continuous activity level rather than a specific, checkable event.)
  • Coterra Energy: Maintain drilling activity with 12 to 13 rigs across Permian, Marcellus, and Anadarko basins · outside the methodology's scope (vague: Maintaining a level of activity is an operational plan rather than a specific, checkable event.)
  • Coterra Energy: Operate drilling rigs and completion crews in the Permian, Marcellus, and Anadarko basins · outside the methodology's scope (vague: Operating rigs and crews is a continuous activity level rather than a specific, checkable event.)
  • Coterra Energy: Operate seven Permian rigs · outside the methodology's scope (vague: Operating rigs is a continuous activity level rather than a specific, checkable event.)
  • Coterra Energy: Provide incremental natural gas volumes · outside the methodology's scope (vague: Providing incremental volumes is a general operational outcome rather than a specific, checkable project milestone.)
  • CytoDyn Inc. (CYDY): Provide continued clinical trial readouts supporting proposed MOA · outside the methodology's scope (vague: Providing continued readouts throughout a period is an ongoing process rather than a specific, checkable event.)
  • Discover Financial: Close the acquisition of Discover Financial Services · outside the methodology's scope (being_acquired: The company is being acquired; this is a deal event for the acquirer, not an operational commitment of the target.)
  • Discover Financial: Begin implementation of the Community Benefits Plan · outside the methodology's scope (being_acquired: This commitment relates to the acquirer (Capital One) following the merger.)
  • Enphase Energy (ENPH): Ship 100 to 120 megawatt hours of Enphase IQ Batteries · outside the methodology's scope (financial: This is a shipment volume target tied to a revenue forecast.)
  • Enphase Energy (ENPH): Ship 1,100,000 units of U.S. manufactured microinverters · outside the methodology's scope (financial: This is a shipment volume forecast tied to financial guidance.)
  • Enphase Energy (ENPH): Ship 160 to 180 megawatt hours of IQ Batteries · outside the methodology's scope (financial: This is a shipment volume forecast tied to financial guidance.)
  • Evaxion A/S (EVAX): Present three-year clinical and immune data from the EVX-01 phase 2 trial at the ESMO 2026 Congress · outside the methodology's scope (event: This is a presentation at a conference.)
  • Glass House Brands Inc. (GLAS): Produce approximately 1,000,000 pounds of biomass · outside the methodology's scope (financial: This is production guidance, which is a performance target.)
  • GSK plc (GSK): Present clinical trial data at the ESMO 2026 Congress · outside the methodology's scope (event: This is a presentation at a conference.)
  • Hess Corporation: Continue operating four drilling rigs in the Bakken in 2024 · outside the methodology's scope (vague: Continuing to operate existing rigs is a routine business activity, not a specific new operational milestone.)
  • Mako Mining Corp. (MAKO): Increase crushing plant throughput to over 12,000 short tons per day at the Moss Mine · outside the methodology's scope (financial: This is a throughput target/performance metric.)
  • Marathon Oil: Maintain an average of six rigs in the Eagle Ford · outside the methodology's scope under the current rules
  • Match Group (MTCH): Launch a marketing campaign for the Share My Date feature · outside the methodology's scope (event: Launching a marketing campaign is a routine corporate/promotional activity.)
  • Match Group (MTCH): Launch a new iteration of the It Starts with a Swipe campaign · outside the methodology's scope (event: Launching a marketing campaign is a routine corporate/promotional activity.)
  • Match Group (MTCH): Achieve positive sequential Payer net additions for Tinder · outside the methodology's scope (financial: This is a performance target (net additions).)
  • Match Group (MTCH): Introduce weekly subscription packages in additional markets · outside the methodology's scope (vague: Introducing subscription packages is a general business strategy rather than a specific, checkable operational milestone.)
  • Match Group (MTCH): Incorporate AI into the onboarding process · outside the methodology's scope (vague: Incorporating AI into an onboarding process is a broad, qualitative initiative without a clear, checkable completion point.)
  • Match Group (MTCH): Roll out AI-driven features in apps · outside the methodology's scope (vague: Rolling out 'many' AI-driven features is a broad, ongoing initiative rather than a specific, checkable operational event.)
  • Match Group (MTCH): Reduce the rate of user declines for Tinder · outside the methodology's scope (vague: This is a performance target/trend rather than a specific, checkable operational milestone.)
  • Match Group (MTCH): Reintroduce Tinder to the Gen Z audience · outside the methodology's scope (vague: Reintroducing a brand to an audience is a marketing strategy, not a specific, checkable operational milestone.)
  • Prologis (PLD): Expire the exchange offers and solicitation of consents · outside the methodology's scope (other: This is a deadline for a financial offer/solicitation, not an operational commitment.)
  • Royal Caribbean Group (RCL): Implement new COVID-19 testing requirements for guests · outside the methodology's scope (other: This is a policy change/operational procedure update, not a capital project or product launch.)
  • STMicroelectronics N.V. (STM): Achieve 100% renewable electricity sourcing · outside the methodology's scope (vague: Renewable energy sourcing goals are typically broad sustainability targets.)
  • STMicroelectronics N.V. (STM): Achieve carbon neutrality in direct and indirect emissions, product transportation, business travel, and employee commuting · outside the methodology's scope (vague: Carbon neutrality goals are often broad sustainability targets rather than specific, checkable operational projects.)
  • VinFast Auto Ltd. (VFS): Conduct a pilot of 200 Level 4 robotaxis at Vinhomes Green Paradise · outside the methodology's scope (third_party: The commitment is explicitly subject to obtaining regulatory approvals.)
  • Vivmark Residential (VMRK): Stabilize the 312-unit development in Washington, D.C · outside the methodology's scope (financial: Stabilization of a property is a financial/occupancy metric.)
  • Vivmark Residential (VMRK): Achieve a blended lease rate between 2.8% and 3.4% in the second quarter of 2025 · outside the methodology's scope (financial: This is a financial performance target (lease rate).)
  • Vivmark Residential (VMRK): Announce the new company name at the transaction closing · outside the methodology's scope (vague: Announcing a name is a corporate communication event, not a core operational commitment.)
  • Welltower (WELL): Complete property dispositions · outside the methodology's scope (financial: This is a financial target regarding disposition proceeds and yield.)
  • Welltower (WELL): Complete pro rata property dispositions and loan repayments · outside the methodology's scope (financial: This is a financial target regarding proceeds and yields.)
Corrections
  • Celanese: deadline corrected from 2019-06-30 to 2019-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Ventas: outcome changed from unresolved to pending · The company's later SEC filings did not clearly show whether this was delivered.

19 Oct 2026

  • 903added
  • 445outcomes recorded
  • 2,414confirmed (53 by tie-break)
  • 138withdrawn from publication
  • 9corrected
Withdrawn: Financial forecast, not an operational deliverable (73), Too vague to check (38), Outside the methodology's scope (15), Depends on a third party, not the company (9), Accounting or internal process (3)
  • AES Corporation (AES): Sign at least 5 GW of contracts for new renewables · outside the methodology's scope (financial: Signing contracts is a commercial/sales activity, not an operational project.)
  • AES Corporation (AES): Exit coal-fired generation · outside the methodology's scope (vague: Exiting coal is a broad strategic goal without a specific, checkable operational milestone.)
  • AES Corporation (AES): Triple installed renewables capacity · outside the methodology's scope (financial: Tripling capacity is a growth/performance target.)
  • AES Corporation (AES): Add 25 to 30 GW of solar, wind and energy storage capacity to the renewables portfolio · outside the methodology's scope (vague: Adding capacity over a multi-year period is a broad growth target rather than a specific, checkable operational milestone.)
  • Albemarle Corporation (ALB): Realign core Lithium and Bromine businesses into Energy Storage and Specialties segments · outside the methodology's scope (vague: Internal corporate restructuring is an organizational change, not a specific operational output like a product launch or facility opening.)
  • Albemarle Corporation (ALB): Close the transaction with Mineral Resources Ltd · outside the methodology's scope (third_party: Closing is contingent on regulatory approvals.)
  • Alexandria Real Estate Equities (ARE): Settle forward equity sales agreements for 699 thousand shares · outside the methodology's scope (financial: Settling equity sales agreements is a financial/capital markets activity, not an operational one.)
  • Alexandria Real Estate Equities (ARE): Place into service and stabilize properties · outside the methodology's scope (financial: Stabilization is a financial/performance metric.)
  • Alexandria Real Estate Equities (ARE): Stabilize development and redevelopment properties · outside the methodology's scope (financial: Stabilization is a financial/occupancy metric for real estate, not a specific operational task.)
  • Alexandria Real Estate Equities (ARE): Prepay the second installment of the ground lease rent obligation · outside the methodology's scope (financial: This is a payment obligation/financial transaction rather than an operational milestone.)
  • Alliant Energy (LNT): Complete the company's historic solar expansion · outside the methodology's scope (vague: Completing a 'historic expansion' is a vague description of ongoing work rather than a specific, checkable project.)
  • Amcor (AMCR): Return leverage to approximately three times · outside the methodology's scope (financial: Returning leverage to a specific ratio is a financial target.)
  • American Water Works (AWK): Close the acquisition of the Granite City, Illinois wastewater treatment plant · outside the methodology's scope (third_party: Closing is contingent on regulatory approval.)
  • Avery Dennison (AVY): Achieve approximately 40% growth in Intelligent Labels organic sales · outside the methodology's scope (financial: This is a financial growth target for sales.)
  • Carnival Corporation (CCL): Ensure eight of nine brands have their entire fleet serving guests · outside the methodology's scope (vague: Ensuring a fleet is serving guests is a broad operational status rather than a specific event.)
  • Carnival Corporation (CCL): Return credit card reserves to the company · outside the methodology's scope (financial: Returning credit card reserves is a balance sheet/financial liquidity item, not an operational project.)
  • Carnival Corporation (CCL): Reduce food waste per person by 40% relative to 2019 baseline · outside the methodology's scope (financial: This is a sustainability/performance target rather than a specific operational project.)
  • Carnival Corporation (CCL): Reduce carbon intensity by more than 20% compared to 2019 levels · outside the methodology's scope (financial: This is a sustainability/performance target rather than a specific operational project.)
  • Casey's (CASY): Add at least 150 stores to the company's network · outside the methodology's scope (financial: Adding stores is a growth target/performance metric.)
  • CF Industries (CF): Reach a final investment decision for the proposed greenfield ammonia production facility · outside the methodology's scope (other: Reaching a final investment decision is a corporate governance/capital allocation decision, not an operational project milestone.)
  • CF Industries (CF): Complete the nitric acid plant emissions abatement project at the Verdigris facility · outside the methodology's scope (vague: The commitment lacks a specific completion date, only stating it begins in 2025.)
  • CF Industries (CF): Obtain permits for the Blue Point project · outside the methodology's scope (third_party: Obtaining permits is a regulatory process dependent on third-party approval.)
  • CF Industries (CF): Secure permits for Blue Point Complex · outside the methodology's scope (third_party: Securing permits is a regulatory process dependent on third-party approval.)
  • CF Industries (CF): Reach final investment decision for the Courtright urea liquor upgrade plant · outside the methodology's scope (vague: A final investment decision is a corporate decision-making milestone, not an operational output like construction or production.)
  • Charter Communications (CHTR): Evolve network to offer symmetrical and multi-gig speeds across its entire footprint · outside the methodology's scope (vague: The commitment to 'evolve network' is too vague and lacks a specific, checkable end point.)
  • Clorox (CLX): Begin implementing the streamlined operating model · outside the methodology's scope (vague: Implementing an operating model is a broad, internal corporate process rather than a specific, checkable operational milestone.)
  • Clorox (CLX): Complete the five-year investment in transformative technologies and processes · outside the methodology's scope (vague: This is a general investment plan over a period, not a specific operational milestone.)
  • Constellation Brands (STZ): Announce a new water stewardship target · outside the methodology's scope (vague: Announcing a target is a corporate communication event, not a substantive operational change.)
  • Constellation Brands (STZ): Ensure 80% of Wine and Spirits packaging is returnable, recyclable, or renewable · outside the methodology's scope (financial: This is a sustainability/performance target rather than a specific operational project.)
  • Constellation Brands (STZ): Attain TRUE Zero Waste to Landfill Certification in key operating facilities · outside the methodology's scope (financial: This is a sustainability/performance target rather than a specific operational project.)
  • Constellation Brands (STZ): Reduce packaging weight to product weight ratio by 10% across Wine and Spirits portfolio · outside the methodology's scope (financial: This is a sustainability/performance target rather than a specific operational project.)
  • Constellation Brands (STZ): Reach 50% female and 30% ethnic diversity in U.S. salaried employee population · outside the methodology's scope (financial: This is a diversity/HR target rather than a specific operational project or asset delivery.)
  • Constellation Energy (CEG): Close the acquisition of a 44% stake in South Texas Project from NRG · outside the methodology's scope (third_party: Closing an acquisition is subject to regulatory approvals.)
  • Corteva (CTVA): Complete the separation into two independent public companies · outside the methodology's scope (other: Corporate restructuring/separation is a strategic event, not a standard operational commitment.)
  • Corteva (CTVA): Make the Form 10 effective · outside the methodology's scope (third_party: The effectiveness of a Form 10 is ultimately determined by the SEC, not solely the company.)
  • Corteva (CTVA): Advance third generation above-ground insect traits in corn · outside the methodology's scope (vague: Advancing traits is a vague, ongoing R&D process without a clear, checkable end point.)
  • CRH plc (CRH): Complete the review of the LSE ordinary share listing and preference share capital structure · outside the methodology's scope (accounting: A corporate review of share structure is an administrative/accounting task, not an operational commitment.)
  • CRH plc (CRH): Reduce absolute carbon emissions by 30% · outside the methodology's scope (financial: This is a performance target (reduction percentage), not a specific operational milestone.)
  • Digital Realty (DLR): Stabilize two data centers in Northern Virginia · outside the methodology's scope (financial: Stabilization in real estate/data centers refers to reaching a specific occupancy or financial performance level.)
  • Digital Realty (DLR): Stabilize the third data center in Northern Virginia · outside the methodology's scope (financial: Stabilization in real estate/data centers refers to reaching a specific occupancy or financial performance level.)
  • Dollar General (DG): Execute approximately 3,170 real estate projects in the United States · outside the methodology's scope (vague: Executing 'real estate projects' is a broad, non-specific operational activity without a clear, checkable end point.)
  • Dollar Tree (DLTR): Grow selling square footage by 3.0% to 3.5% for fiscal 2023 · outside the methodology's scope (financial: Square footage growth is a financial/performance target.)
  • Domino's (DPZ): Enable ordering on Uber Eats and Postmates apps across the U.S · outside the methodology's scope (already_done: The date (end of 2023) has passed.)
  • DoorDash (DASH): Extend the gas savings program for Dashers · outside the methodology's scope (vague: Extending a program is an ongoing operational status rather than a specific, one-time completion event.)
  • eBay Inc. (EBAY): Add hundreds of thousands of items to the eBay Refurbished program · outside the methodology's scope (vague: Adding items to a program is an ongoing operational activity without a specific, checkable end point.)
  • Extra Space Storage (EXR): Expire the exchange offers for Life Storage notes · outside the methodology's scope (other: This is a financial transaction deadline, not an operational commitment.)
  • Extra Space Storage (EXR): Consummate the merger with LSI and Life Storage OP · outside the methodology's scope (third_party: Closing a merger is subject to regulatory and shareholder approvals.)
  • Ford Motor Company (F): Increase production of electric vehicles · outside the methodology's scope (vague: The commitment to 'increase production' is vague and lacks a specific, checkable end point or target quantity.)
  • Ford Motor Company (F): Achieve global electric vehicle production run rate of 600,000 units · outside the methodology's scope (financial: Production run-rate targets are performance metrics.)
  • Ford Motor Company (F): Deliver an annual run rate of 600,000 electric vehicles globally · outside the methodology's scope (financial: This is a production volume target/run rate, which is a performance metric.)
  • Ford Motor Company (F): Scale F-150 Lightning annual production run rate to 150,000 units · outside the methodology's scope (financial: Production run-rate targets are performance metrics.)
  • Ford Motor Company (F): Achieve global electric vehicle production run rate of two million units · outside the methodology's scope (financial: Production run-rate targets are performance metrics.)
  • Freeport-McMoRan (FCX): Commence copper concentrate exports · outside the methodology's scope (already_done: The date (July 2023) has passed.)
  • Freeport-McMoRan (FCX): Commission the Manyar Greenfield Smelter · outside the methodology's scope (already_done: The date (2024) has passed.)
  • Freeport-McMoRan (FCX): Achieve first production of copper cathode at the new Indonesia smelter · outside the methodology's scope (already_done: The date (July 2025) has passed relative to the announcement date context.)
  • Freeport-McMoRan (FCX): Make investment decision for Bagdad Expansion · outside the methodology's scope (vague: An investment decision is a corporate governance/strategic step, not a direct operational action like construction or production.)
  • Freeport-McMoRan (FCX): Complete the investigation into the mud rush incident · outside the methodology's scope (other: An internal investigation is an administrative/corporate process, not an operational activity.)
  • Freeport-McMoRan (FCX): Complete the investigation into the Grasberg Block Cave mine incident · outside the methodology's scope (other: An internal investigation is an administrative/corporate process, not an operational activity like production or construction.)
  • Freeport-McMoRan (FCX): Address bottlenecks at Grasberg Block Cave · outside the methodology's scope (vague: Addressing bottlenecks is an open-ended, non-specific operational improvement.)
  • General Mills (GIS): Complete the impacts of the Häagen-Dazs ice cream recall · outside the methodology's scope (vague: Completing the 'impacts' of a recall is not a specific, checkable operational milestone.)
  • and 78 more in the file above.
Corrections
  • Albemarle Corporation: deadline corrected from 2022-06-30 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Albemarle Corporation: deadline corrected from 2023-06-30 to 2023-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Avery Dennison: deadline corrected from 2016-06-30 to 2016-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Avery Dennison: deadline corrected from 2017-06-30 to 2017-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Cbre Group: deadline corrected from 2021-03-31 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Equinix: deadline corrected from 2021-03-31 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Healthpeak Properties: deadline corrected from 2019-06-30 to 2019-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Mosaic Company (The): deadline corrected from 2025-07-01 to 2025-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Mosaic Company (The): deadline corrected from 2026-03-31 to 2026-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

18 Oct 2026

  • 1,185added
  • 557outcomes recorded
  • 149confirmed
  • 49withdrawn from publication
  • 8corrected
Withdrawn: Financial forecast, not an operational deliverable (21), Too vague to check (18), Depends on a third party, not the company (5), Outside the methodology's scope (4), Accounting or internal process (1)
  • AES Corporation (AES): Add 3.6 GW of new renewable projects to the operating portfolio · outside the methodology's scope (financial: This is a capacity addition target, often treated as a performance/growth metric.)
  • American Water Works (AWK): Seek PUC approval of the proposed acquisition of the Elizabeth Borough Municipal Authority wastewater system · outside the methodology's scope (third_party: Seeking regulatory approval is a third-party process.)
  • Bunge Global (BG): Close the acquisition of Viterra · outside the methodology's scope (assumption: This is a statement about what is excluded from a forecast, not a commitment to close.)
  • Carnival Corporation (CCL): Achieve more than a 20 percent reduction in GHG emission intensity compared to 2019 · outside the methodology's scope (financial: This is a performance target related to GHG emission intensity reduction.)
  • Carnival Corporation (CCL): Increase Carnival Cruise Line's share of the company's portfolio to 37 percent · outside the methodology's scope (financial: This is a portfolio mix/percentage target, not a specific operational milestone.)
  • Casey's (CASY): Add approximately 270 stores · outside the methodology's scope (vague: Adding stores is a general growth plan without a specific, checkable end point or location list.)
  • Church & Dwight (CHD): Complete major capacity investments · outside the methodology's scope (vague: Completing 'major capacity investments' is too vague to be a checkable operational milestone.)
  • Church & Dwight (CHD): Complete ERP upgrade project · outside the methodology's scope (accounting: This is an internal IT/accounting project mentioned in the context of financial expense exclusions.)
  • Church & Dwight (CHD): Reach a conclusion from the strategic review of the vitamin business · outside the methodology's scope (vague: A strategic review is a process, not a specific operational output like a launch or construction completion.)
  • Church & Dwight (CHD): Conclude the strategic review of the Vitamin brands · outside the methodology's scope (vague: A strategic review is a process, not a specific operational output.)
  • CMS Energy (CMS): File the next Renewable Energy Plan (REP) with Michigan regulators · outside the methodology's scope (third_party: Regulatory filings are driven by regulatory schedules and requirements.)
  • Consolidated Edison (ED): Submit Stage 2 compliance filings for the Utility Thermal Energy Network pilot projects · outside the methodology's scope (third_party: This is a regulatory filing deadline, not an internal operational commitment.)
  • Consolidated Edison (ED): Submit the next combined gas system long-term plan (GSLTP) filing · outside the methodology's scope (third_party: Regulatory filings are often driven by regulatory schedules and requirements.)
  • Constellation Brands (STZ): Continue development of modular additions at existing facilities in Mexico and the third brewery site at Veracruz · outside the methodology's scope (vague: This is a broad capital expenditure plan over several years rather than a specific, checkable operational milestone.)
  • Domino's (DPZ): Achieve 3% or more of sales through the Uber Eats channel · outside the methodology's scope (financial: This is a sales/performance target.)
  • DoorDash (DASH): Reduce legal expenses · outside the methodology's scope (financial: This is a financial expense target, not an operational milestone.)
  • DoorDash (DASH): Turn unit economics in grocery and retail categories positive · outside the methodology's scope (financial: This is a financial performance target (unit economics).)
  • DoorDash (DASH): Deliver a high single-digit percentage of orders using Dot robots in the largest test market · outside the methodology's scope (financial: This is a performance target (percentage of orders) rather than a specific operational milestone.)
  • DTE Energy (DTE): Reduce power outages by 30% and halve outage time on the electric grid · outside the methodology's scope (vague: This is a broad performance goal/improvement target rather than a specific operational project.)
  • DTE Energy (DTE): Reduce power outages by 30% and cut outage duration in half · outside the methodology's scope (financial: Reducing outages by a percentage is a performance target, not a specific operational project completion.)
  • eBay Inc. (EBAY): Scale value-added services including advertising, financial services, and shipping value propositions · outside the methodology's scope (vague: Scaling a value proposition is a broad, ongoing operational effort without a clear, singular completion point.)
  • Estée Lauder Companies (The) (EL): Complete approvals for specific initiatives under the restructuring program · outside the methodology's scope (accounting: This refers to internal approvals for a restructuring program, which is an administrative/accounting step.)
  • Estée Lauder Companies (The) (EL): Fully deploy the One Operating Ecosystem · outside the methodology's scope (vague: Deploying an 'operating ecosystem' is too vague to be a checkable operational milestone.)
  • FirstEnergy (FE): Submit applications for rehearing on the PUCO's ESP V Order · outside the methodology's scope (third_party: The company is describing a regulatory deadline for a filing, not committing to an internal operational milestone.)
  • Ford Motor Company (F): Refresh 60% of Ford Blue’s global vehicle lineup · outside the methodology's scope (vague: Refreshing a lineup is a broad strategic goal rather than a specific, checkable operational project.)
  • Ford Motor Company (F): Kick off a 23-store Bronco Filson North American tour · outside the methodology's scope (event: This is a marketing/promotional event (a tour).)
  • Genuine Parts Company (GPC): Complete the settlement of the U.S. pension plan termination · outside the methodology's scope (accounting: Pension plan termination and settlement is an accounting/financial process.)
  • Hershey Company (The) (HSY): Reverse accelerated shipments related to the ERP implementation · outside the methodology's scope (vague: Reversing shipments is an accounting/inventory adjustment, not a clear operational commitment.)
  • Kenvue (KVUE): Close the acquisition of Kenvue · outside the methodology's scope (being_acquired: The entry describes Kenvue being acquired, which is an event for the acquirer, not the target.)
  • Kimberly-Clark (KMB): Launch new product innovation and commercial activation lineup · outside the methodology's scope (vague: Launching an 'innovation and commercial activation lineup' is too vague to be a checkable operational milestone.)
  • Kimberly-Clark (KMB): Complete the 2024 Transformation Initiative · outside the methodology's scope (vague: Transformation initiatives are typically broad, non-specific corporate programs.)
  • Kroger (KR): Extend the expiration date of the exchange offers and consent solicitations · outside the methodology's scope (other: This is a routine administrative extension of a financial offer period, not a core operational commitment.)
  • Kroger (KR): Complete the exchange offers and consent solicitations for Albertsons notes · outside the methodology's scope (financial: This is a financial transaction (exchange offer/consent solicitation) rather than an operational commitment.)
  • Lennar (LEN): Deliver between 19,000 and 19,500 homes · outside the methodology's scope (financial: This is a volume delivery target/forecast, which is a financial/performance metric.)
  • Lennar (LEN): Deliver 80,000 homes for the full year · outside the methodology's scope (financial: This is a volume delivery target/forecast, which is a financial/performance metric.)
  • News Corp (Class B) (NWSA): Publish the announcement on the company website · outside the methodology's scope (other: This is a routine administrative disclosure requirement, not a core operational commitment.)
  • Oneok (OKE): Make a final investment decision on the Saguaro Connector Pipeline · outside the methodology's scope (other: A final investment decision is a corporate governance/financial decision, not an operational commitment to build.)
  • Reddit (RDDT): Expand machine translation to over 30 countries · outside the methodology's scope (vague: Expanding a feature to 'over 30 countries' is a broad, ongoing operational initiative without a clear, singular completion point.)
  • Reddit (RDDT): Expand machine translation to additional markets · outside the methodology's scope (vague: Expanding to 'additional markets' is an open-ended growth plan without a specific, checkable end point.)
  • Royal Caribbean Group (RCL): Achieve Trifecta goals · outside the methodology's scope (financial: Trifecta goals are financial/performance targets (EBITDA, ROIC, etc.).)
  • Royal Caribbean Group (RCL): Increase land-based destination portfolio to eight · outside the methodology's scope (financial: Increasing a portfolio count is a strategic/financial target rather than a specific operational project.)
  • TJX Companies (TJX): Increase store opening growth rate to 4% · outside the methodology's scope (financial: This is a financial/growth rate target rather than a specific operational milestone.)
  • Tractor Supply (TSCO): Provide an updated long-term financial framework · outside the methodology's scope (financial: Providing a financial framework is a corporate/financial reporting event, not an operational milestone.)
  • Ulta Beauty (ULTA): Conclude the Ulta Beauty at Target shop-in-shop partnership · outside the methodology's scope (vague: Concluding a partnership is a business relationship change, not a specific operational project like a launch or construction.)
  • Wynn Resorts (WYNN): Submit the report on the execution of the previous year's execution proposal to the Macau government · outside the methodology's scope (vague: This describes a recurring annual requirement rather than a specific, one-time operational commitment.)
  • Yum! Brands (YUM): Reach 30,000 KFC restaurants globally · outside the methodology's scope (vague: Reaching a store count is a performance target/milestone rather than a specific operational project.)
  • Yum! Brands (YUM): Surpass 60,000 restaurants · outside the methodology's scope (financial: This is a growth target/milestone rather than a specific operational project.)
  • Yum! Brands (YUM): Scale the Live Más Café beverage concept to 30 locations · outside the methodology's scope (financial: Scaling a concept to a specific number of locations is a growth/performance target.)
  • Yum! Brands (YUM): Implement core strategy elements across KFC's Top 20 markets · outside the methodology's scope (vague: Implementing 'core strategy elements' is too vague and lacks a clear, checkable operational definition.)
Corrections
  • Church & Dwight: deadline corrected from 2022-07-31 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Dollar Tree: deadline corrected from 2018-01-30 to 2017-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Dollar Tree: deadline corrected from 2020-01-30 to 2019-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Dollar Tree: deadline corrected from 2020-01-30 to 2019-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Dollar Tree: deadline corrected from 2023-01-30 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Lennar: deadline corrected from 2021-11-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Ross Stores: deadline corrected from 2019-02-02 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Ross Stores: outcome changed from kept to late · Ross Stores opened 100 net new stores during fiscal 2018, meeting its stated commitment of approximately 100 new locations.

17 Oct 2026

  • 1,050added
  • 540outcomes recorded
  • 187confirmed
  • 44withdrawn from publication
  • 4corrected
Withdrawn: Too vague to check (24), Financial forecast, not an operational deliverable (12), Accounting or internal process (3), Depends on a third party, not the company (3), Outside the methodology's scope (2)
  • AES Corporation (AES): Add 3.2 GW to its operating portfolio by year-end 2025 · outside the methodology's scope (financial: Adding capacity to a portfolio is a performance/growth target.)
  • AES Corporation (AES): Sign new long-term renewables PPAs totalling 14-17 GW for 2023 through 2025 · outside the methodology's scope (vague: Signing PPAs is a commercial/contractual activity, not a specific operational milestone like construction or launch.)
  • Airbnb (ABNB): Roll out AI-powered customer service agent to additional countries and languages · outside the methodology's scope (vague: The commitment to roll out to 'more countries' is open-ended and lacks a specific, checkable end point.)
  • Airbnb (ABNB): Expand availability of flexible location carousels · outside the methodology's scope (vague: Broader availability is a vague target without a specific, checkable operational milestone.)
  • Airbnb (ABNB): Expand services and experiences offerings · outside the methodology's scope (vague: The commitment to 'expand services' is too broad and lacks a specific, checkable operational endpoint.)
  • Airbnb (ABNB): Expand hotel pilot to other key markets · outside the methodology's scope (vague: Expansion to 'other key markets' is too vague to be a checkable operational commitment.)
  • Airbnb (ABNB): Make Reserve Now, Pay Later available to more guests globally · outside the methodology's scope (vague: Expanding a feature to 'more guests' is not a specific, checkable operational milestone.)
  • Airbnb (ABNB): Roll out AI customer support globally · outside the methodology's scope (vague: Rolling out a feature 'globally' without specific milestones is too vague.)
  • Carnival Corporation (CCL): Reduce greenhouse gas emissions rate by more than 25 percent compared to 2019 levels · outside the methodology's scope (financial: This is a performance target (emissions reduction percentage).)
  • Carvana (CVNA): Integrate additional ADESA locations · outside the methodology's scope (vague: The commitment to 'integrate' locations at a 'similar rate' is not a specific, checkable operational milestone.)
  • CenterPoint Energy (CNP): Deliver 10 gigawatts of new peak load in Greater Houston by end of 2029 · outside the methodology's scope (financial: This is framed as a projection of load delivery, which functions as a capacity/performance target.)
  • Charter Communications (CHTR): Complete the network evolution initiative · outside the methodology's scope (vague: Network evolution is a broad, ongoing initiative without a clear, singular operational 'completion' event.)
  • Charter Communications (CHTR): Apply Spectrum's workforce model to Cox markets and return Cox customer service to the U.S · outside the methodology's scope (vague: The commitment to apply a workforce model is an ongoing operational process without a clear, discrete completion event.)
  • Chipotle Mexican Grill (CMG): Include Chipotlanes in approximately 80% of new company-owned restaurants · outside the methodology's scope (vague: This is a general design/construction standard for new stores rather than a specific, checkable operational milestone.)
  • Chipotle Mexican Grill (CMG): Equip approximately 80% of company-owned restaurants with a Chipotlane · outside the methodology's scope (financial: This is a target percentage of store retrofits, which is a performance/capital allocation target.)
  • DTE Energy (DTE): Trim over 6,500 miles of trees · outside the methodology's scope (vague: Tree trimming is a routine operational maintenance activity rather than a specific, one-time project completion.)
  • DTE Energy (DTE): Reach final terms with an additional data center customer · outside the methodology's scope (vague: Reaching terms with a customer is a commercial negotiation, not a clear operational milestone.)
  • DTE Energy (DTE): Reduce electric outages by 30% and customer time without power by 50% against baseline · outside the methodology's scope (financial: These are performance/service level targets, not specific operational projects.)
  • Equinox Gold Corp. (EQX): Achieve consolidated 2026 gold production of 870,000 to 920,000 oz · outside the methodology's scope (financial: This is a production volume guidance/target.)
  • Fortuna Mining Corp. (FSM): Prepare an updated Southern Arc Mineral Resource and Mineral Reserve estimate · outside the methodology's scope (vague: Preparing an estimate is a routine internal process without a clear, checkable operational outcome.)
  • Fortuna Mining Corp. (FSM): Include initial Kabewest Inferred Mineral Resource estimate in annual Mineral Reserve and Resource update · outside the methodology's scope (accounting: This is a routine corporate reporting/disclosure update, not an operational project.)
  • Fractyl Health, Inc. (GUTS): Submit De Novo marketing application to the FDA · outside the methodology's scope (third_party: Regulatory submission is a regulatory action/process.)
  • Fractyl Health, Inc. (GUTS): Submit De Novo marketing application for the Revita DMR System · outside the methodology's scope (third_party: Regulatory submission is a regulatory action/process.)
  • International Seaways, Inc. (INSW): Settle the First-Step Exchange transactions with Bruton shareholders · outside the methodology's scope (other: Settlement of financial exchange transactions is a financial/corporate event, not an operational commitment.)
  • Li Auto Inc. (LI): Allow Hangzhou Jingtao to exercise its subscription right to invest in MHX Technology · outside the methodology's scope (other: This is a financial investment right/option, not an operational commitment.)
  • Live Nation Entertainment (LYV): Open large venues via new builds and acquisitions planned for 2026 · outside the methodology's scope (vague: The commitment is tied to a fan-count performance metric rather than a specific, checkable operational milestone.)
  • NRG Energy (NRG): Reach 150 MW of Texas Residential Virtual Power Plant capacity · outside the methodology's scope (financial: This is a capacity target/performance goal rather than a specific operational project.)
  • NRG Energy (NRG): Reach 650 MW of Texas Residential Virtual Power Plant capacity · outside the methodology's scope (financial: This is a capacity target/performance goal.)
  • Nuran Wireless Inc. (NUR): Expand the operating network to 1,650 sites · outside the methodology's scope (vague: Targeting an expansion subject to financing is a vague plan, not a firm commitment.)
  • Paramount Skydance Corporation (SKYD): Host UFC 326 in Las Vegas · outside the methodology's scope (other: The commitment refers to a third-party event (UFC) rather than an operational milestone of the company itself.)
  • Paramount Skydance Corporation (SKYD): Update the Pluto TV platform · outside the methodology's scope (vague: An 'update' to a platform is too vague to be a checkable operational commitment without specific details.)
  • Paramount Skydance Corporation (SKYD): Release over 90 series and 800+ episodes from TV studios in 2026 · outside the methodology's scope (vague: This is a general production volume target rather than a specific, checkable operational milestone.)
  • Paramount Skydance Corporation (SKYD): Grow theatrical output to at least 15 films annually · outside the methodology's scope (vague: Growing theatrical output is a general business plan/target rather than a specific, checkable operational milestone.)
  • Recursion Pharmaceuticals, Inc. (RXRX): Initiate a registrational trial of REC-4881 in FAP, pending FDA discussions · outside the methodology's scope (third_party: The commitment is explicitly contingent on the outcome of FDA discussions.)
  • Reddit (RDDT): Expand international playbook to additional markets · outside the methodology's scope (vague: The commitment to expand to 'additional markets' lacks a defined, checkable end point.)
  • Reddit (RDDT): Roll out new features to drive engagement and premium content · outside the methodology's scope (vague: Rolling out 'new features' to 'drive engagement' is too generic and lacks a specific, checkable deliverable.)
  • Reddit (RDDT): Expand AI-powered search to new languages · outside the methodology's scope (vague: Expanding to 'new languages' is not a specific, checkable operational milestone.)
  • RIO Tinto Ltd. (RTNTF): Reach a 60 Mtpa Simandou iron ore production run-rate during H2 2028 · outside the methodology's scope (financial: This is a production run-rate target, which is a performance/operational metric rather than a specific project completion.)
  • Sealsq Corp (LAES): Complete the QS7001 V1 Common Criteria Hardware Evaluation Test Report · outside the methodology's scope (accounting: Completing a test report is an administrative/accounting/compliance step.)
  • Sealsq Corp (LAES): Complete the V2 full post-quantum report · outside the methodology's scope (accounting: Completing a report is an administrative/compliance step.)
  • Standard Lithium Ltd. (SLI): Make a Final Investment Decision on the SWA Project · outside the methodology's scope (vague: A Final Investment Decision is a corporate/financial decision, not an operational commitment.)
  • TKO Group Holdings (TKO): Deliver the next UFC domestic media rights deal · outside the methodology's scope (vague: Delivering a deal is a negotiation process, not a specific operational milestone.)
  • TKO Group Holdings (TKO): Launch UFC content on Paramount · outside the methodology's scope (vague: The commitment is about an agreement/contract start date rather than a specific operational launch of a product or facility.)
  • Warner Bros. Discovery (WBD): Close the acquisition of Warner Bros. Discovery · outside the methodology's scope (being_acquired: The company is the target of the acquisition, not the acquirer.)
Corrections
  • Charter Communications: deadline corrected from 2027-08-20 to 2027-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Take-Two Interactive: deadline corrected from 2021-06-21 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Take-Two Interactive: deadline corrected from 2023-03-31 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Take-Two Interactive: deadline corrected from 2023-03-31 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

16 Oct 2026

  • 350added
  • 118outcomes recorded
  • 4corrected
Corrections
  • Edison International: deadline corrected from 2022-04-30 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Edison International: deadline corrected from 2023-09-30 to 2023-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Sempra: deadline corrected from 2023-09-30 to 2023-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Sempra: deadline corrected from 2023-09-30 to 2023-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

15 Oct 2026

  • 913added
  • 246outcomes recorded
  • 50confirmed
  • 57withdrawn from publication
Withdrawn: Too vague to check (25), Financial forecast, not an operational deliverable (20), Outside the methodology's scope (7), Depends on a third party, not the company (4), Accounting or internal process (1)
  • CervoMed Inc. (CRVO): Present 24-week biomarker data from the Phase 2a nfvPPA trial · outside the methodology's scope (event: Presenting data at a conference is a routine corporate event.)
  • Churchill Capital Corp XI (CCXI): Grow the customer pipeline to approximately 100 potential customers · outside the methodology's scope (financial: Growing a customer pipeline is a performance/business target, not a specific operational task.)
  • Devon Energy (DVN): Produce between 550,000 and 560,000 barrels of oil per day · outside the methodology's scope (financial: This is a production volume target/guidance, which is a performance metric.)
  • Devon Energy (DVN): Produce between 1,660,000 and 1,690,000 Boe per day · outside the methodology's scope (financial: Production guidance is a performance target.)
  • Diamondback Energy (FANG): Drill 270 to 290 gross horizontal wells · outside the methodology's scope (financial: This is a production/drilling activity target, which functions as a performance target.)
  • Diamondback Energy (FANG): Convert 25% of proved undeveloped reserves to proved developed category · outside the methodology's scope (financial: This is a reserve conversion target, which is a performance/financial metric.)
  • Diamondback Energy (FANG): Implement simulfrac or simulfrac e-fleet for the majority of well completions · outside the methodology's scope (vague: This is a general operational plan/methodology change rather than a specific, checkable project completion.)
  • Diamondback Energy (FANG): Complete the finishing of 330 to 345 wells · outside the methodology's scope (financial: This is a production/activity target (well count), not a specific operational milestone.)
  • Diamondback Energy (FANG): Complete the drilling of 335 to 350 wells · outside the methodology's scope (financial: This is a production/activity target (well count), not a specific operational milestone.)
  • Diamondback Energy (FANG): Drill 340 to 350 wells in 2023 · outside the methodology's scope (already_done: The commitment refers to 2023, which has passed.)
  • Diamondback Energy (FANG): Turn 325 to 335 wells to production in 2023 · outside the methodology's scope (already_done: The commitment refers to 2023, which has passed.)
  • Diamondback Energy (FANG): Drill 325 to 345 gross horizontal wells · outside the methodology's scope (financial: This is a production/activity target (well count), not a specific operational milestone.)
  • Diamondback Energy (FANG): Drill 335 to 350 gross horizontal wells · outside the methodology's scope (financial: This is a production/activity target (well count), not a specific operational milestone.)
  • Diamondback Energy (FANG): Develop 86% of 2021 year-end proved undeveloped reserves · outside the methodology's scope (financial: This is a reserve development target, which is a performance/financial metric.)
  • Diamondback Energy (FANG): Execute development using SimulFrac completions crews · outside the methodology's scope (vague: Executing development is a general operational plan, not a specific, checkable project completion.)
  • Diamondback Energy (FANG): Reduce rig and completion crew count · outside the methodology's scope (vague: This describes a reduction in activity levels rather than a specific, checkable operational end-point.)
  • Diamondback Energy (FANG): Drill approximately 30 more gross wells and complete 10 fewer wells · outside the methodology's scope (vague: This is a relative adjustment to a plan rather than a specific operational target.)
  • Diamondback Energy (FANG): Develop 80% of consolidated 2022 year-end PUD reserves · outside the methodology's scope (vague: Developing reserves is a broad operational strategy rather than a specific, discrete project.)
  • Diamondback Energy (FANG): Drill approximately 460 wells and complete approximately 575 wells · outside the methodology's scope (vague: Drilling and completion counts are operational targets/plans rather than specific, discrete project completions.)
  • Diamondback Energy (FANG): Average five completion crews · outside the methodology's scope (vague: Averaging a number of crews is an operational plan/target, not a discrete project completion.)
  • Diamondback Energy (FANG): Drill 445-465 gross wells and complete 510-520 gross wells in 2025 · outside the methodology's scope (already_done: The commitment refers to the year 2025, which has passed.)
  • Diamondback Energy (FANG): Operate 13 to 14 rigs and five completion crews · outside the methodology's scope (vague: Operating a range of rigs is a general operational plan rather than a specific, checkable end-point commitment.)
  • Diamondback Energy (FANG): Achieve Q3 total production of 995 - 1,015 MBOE/d · outside the methodology's scope (financial: Production guidance is a performance target.)
  • Diamondback Energy (FANG): Achieve Q3 oil production of 517 - 527 MBO/d · outside the methodology's scope (financial: Production guidance is a performance target.)
  • Diamondback Energy (FANG): Achieve annual oil production of 522+ MBO/d · outside the methodology's scope (financial: Production guidance is a performance target.)
  • Diamondback Energy (FANG): Achieve annual total production of 1,000+ MBOE/d · outside the methodology's scope (financial: Production guidance is a performance target.)
  • EOG Resources (EOG): Reduce total well costs by 5 percent · outside the methodology's scope (financial: This is a financial/performance target regarding cost reduction percentages.)
  • EOG Resources (EOG): Reduce well costs by 5 percent for the year · outside the methodology's scope (financial: This is a financial/performance target regarding cost reduction percentages.)
  • EQT Corporation (EQT): Maintain three horizontal rigs · outside the methodology's scope under the current rules
  • EQT Corporation (EQT): Reduce annual capital costs by 10% · outside the methodology's scope (financial: This is a financial target regarding cost reduction percentages.)
  • EQT Corporation (EQT): Execute planned well drilling and completion activity for the third quarter of 2021 · outside the methodology's scope (vague: Routine operational activity (drilling/completion) is not a specific, checkable project milestone.)
  • EQT Corporation (EQT): Obtain full visibility of the next-generation well design investment · outside the methodology's scope (vague: Obtaining 'visibility' is not a concrete, checkable operational output.)
  • EQT Corporation (EQT): Achieve net zero Scope 1 and Scope 2 GHG emissions · outside the methodology's scope (vague: Long-term sustainability target without a specific operational project.)
  • EQT Corporation (EQT): Achieve emissions reduction goals · outside the methodology's scope (vague: Achieving broad 'emissions reduction goals' is not a specific, checkable operational action.)
  • Eton Pharmaceuticals, Inc. (ETON): Launch LIBERVANT buccal film commercially · outside the methodology's scope (third_party: The commitment is explicitly contingent on final FDA approval, which is a third-party regulatory action.)
  • Expand Energy (EXE): Increase PRB oil flowing on the gathering system to 75% · outside the methodology's scope (vague: This is a vague operational target for percentage growth of flow.)
  • Expand Energy (EXE): Conclude the offering period for the warrant exchange offers · outside the methodology's scope (other: This is a corporate financial transaction/offering, not an operational commitment.)
  • Expand Energy (EXE): Achieve RSG certification of the Chief position in the Marcellus · outside the methodology's scope (vague: RSG certification is a third-party verification process, not a direct operational construction or launch.)
  • Expand Energy (EXE): Publish the 2023 sustainability report · outside the methodology's scope (accounting: Publishing a sustainability report is a routine corporate/accounting disclosure.)
  • Expand Energy (EXE): Achieve GHG intensity of less than 3.0 mt CO2e/boe · outside the methodology's scope (vague: This is an ESG target/goal rather than a specific operational project or milestone.)
  • Expand Energy (EXE): Reduce methane intensity to 0.09% · outside the methodology's scope (vague: This is a long-term sustainability target without a defined operational project or milestone.)
  • Expand Energy (EXE): Achieve methane intensity of 0.02% · outside the methodology's scope (vague: This is an ESG target/goal rather than a specific operational project or milestone.)
  • Expand Energy (EXE): Operate 10 to 12 rigs in 2025 · outside the methodology's scope (vague: Operating a range of rigs is an operational plan/target, not a discrete project completion.)
  • Getty Images Holdings, Inc. (GETY): Complete the restructuring process · outside the methodology's scope (vague: Restructuring is a broad, open-ended corporate process without a clear, checkable end point.)
  • Iron Horse Acquisition II Corp. (IRHO): Join the Westbrook Racing team trackside at the Miami Races · outside the methodology's scope (event: Attending a race is a routine corporate event/participation.)
  • Johnson & Johnson (JNJ): Complete the Orthopaedics franchise restructuring program · outside the methodology's scope (vague: Restructuring programs are generally considered vague corporate initiatives rather than specific operational tasks.)
  • Johnson & Johnson (JNJ): Complete the Surgery franchise restructuring program · outside the methodology's scope (vague: Restructuring programs are generally considered vague corporate initiatives rather than specific operational tasks.)
  • Johnson & Johnson (JNJ): Complete the supply chain restructuring program · outside the methodology's scope (vague: Restructuring programs are generally considered vague corporate initiatives rather than specific operational tasks.)
  • Kimberly Clark Corp. (KMB): Expire the exchange offers for Kenvue notes · outside the methodology's scope (other: This is a financial transaction/offer expiration, not an operational commitment.)
  • Kinder Morgan (KMI): Launch responsibly sourced natural gas supply aggregation pooling service · outside the methodology's scope (third_party: The launch is explicitly contingent on regulatory approval from FERC.)
  • Kinder Morgan (KMI): Make the RSG supply aggregation pooling service available · outside the methodology's scope (third_party: Availability is explicitly contingent on regulatory approval from FERC.)
  • Kinder Morgan (KMI): File for a Notice to Proceed for the remaining compressor station · outside the methodology's scope (third_party: Filing for a permit/notice to proceed is a regulatory step dependent on external approval.)
  • Kinder Morgan (KMI): Place the first Bakken egress project into service · outside the methodology's scope (already_done: The commitment refers to Q4 2023, which has passed.)
  • Mesa Laboratories Inc. (MLAB): Complete the restructuring program · outside the methodology's scope (vague: Restructuring programs are generally considered vague corporate initiatives without a single, checkable operational endpoint.)
  • National Fuel Gas Co. (NFG): Increase firm transportation capacity by 215 MDth/d · outside the methodology's scope (vague: The commitment is a general capacity increase target without a specific, checkable operational milestone.)
  • Sizzle Acquisition Corp. II (SZZL): Reach annual production volume exceeding 500,000 tons at the La Magona plant · outside the methodology's scope (financial: This is a production volume target, which functions as a performance/financial target.)
  • Unitedhealth Group Inc. (UNH): Standardize prior approval requirements for electronic submissions · outside the methodology's scope (vague: Standardizing requirements is an ongoing process/initiative rather than a single, checkable operational event.)

13 Oct 2026

  • 792added
  • 260outcomes recorded
  • 238withdrawn from publication
  • 6corrected
Withdrawn: Too vague to check (93), Financial forecast, not an operational deliverable (86), Depends on a third party, not the company (27), Outside the methodology's scope (21), Accounting or internal process (11)
  • AbbVie Inc. (ABBV): Submit VIALE-A and VIALE-C study results to global health authorities · outside the methodology's scope (third_party: Submitting results for regulatory approval is a regulatory action/process involving third-party approval.)
  • Accenture plc (ACN): Record a pension plan settlement charge · outside the methodology's scope (accounting: Recording a pension settlement charge is an accounting/financial reporting event.)
  • Allstate (ALL): Make the affordable, simple and connected auto insurance product available in more states · outside the methodology's scope (vague: Expanding availability to 'more states' is a vague operational plan without a specific, checkable end point.)
  • Altria Group, Inc. (MO): Begin court-ordered communications about cigarettes and smoking on television and in newspapers · outside the methodology's scope (third_party: This is a court-ordered action, not a voluntary operational commitment.)
  • Altria Group, Inc. (MO): Perform a quantitative assessment of the JUUL investment · outside the methodology's scope (accounting: This is an internal accounting/assessment process.)
  • Amazon COM Inc. (AMZN): Match donations to Friendship Place · outside the methodology's scope (financial: Matching donations is a financial commitment/charitable activity, not an operational one.)
  • Amazon COM Inc. (AMZN): Create more than 100,000 new, full-time, full-benefit jobs in the U.S · outside the methodology's scope (vague: Hiring targets are generally considered vague or financial/performance targets rather than specific operational milestones.)
  • Amazon COM Inc. (AMZN): Reach 20,000 participants in the Career Choice program · outside the methodology's scope (vague: Reaching a participant count in a program is a vague, non-operational target.)
  • Amazon COM Inc. (AMZN): Reach 80% renewable energy usage · outside the methodology's scope (financial: This is a sustainability/performance target rather than a specific operational milestone.)
  • Amazon COM Inc. (AMZN): Run on 100% renewable energy · outside the methodology's scope (vague: This is a broad, long-term corporate goal rather than a specific, checkable operational milestone.)
  • Amazon COM Inc. (AMZN): Create an additional one million jobs in India · outside the methodology's scope (vague: Creating jobs is a broad, non-operational target that is difficult to verify as a specific operational task.)
  • American Express Co. (AXP): Maintain no COVID-19-related layoffs · outside the methodology's scope (vague: Maintaining no layoffs is a broad policy commitment rather than a specific operational milestone.)
  • Amgen Inc. (AMGN): Present updated results from Phase 1 study of AMG 330 at the ASCO20 Virtual Scientific Program · outside the methodology's scope (event: Presenting results at a conference is a routine corporate event.)
  • Amgen Inc. (AMGN): Present clinical data from Phase 1 studies at the ASCO20 Virtual Scientific Program · outside the methodology's scope (event: Presenting clinical data at a conference is a routine corporate event.)
  • Aon plc (AON): Close the acquisition of NFP, expected to complete during 2024 · outside the methodology's scope (assumption: The company explicitly states this date is a model assumption, not a firm commitment.)
  • APA Corporation (APA): Implement a future-of-work strategy · outside the methodology's scope (vague: Implementing a 'future-of-work strategy' is an open-ended plan without a checkable end point.)
  • APA Corporation (APA): Establish a supplier diversity program · outside the methodology's scope (vague: Establishing a program is a general initiative without a specific, checkable operational milestone.)
  • APA Corporation (APA): Reduce upstream routine flaring in Egypt by 40% · outside the methodology's scope (financial: Reducing flaring by a percentage is a performance target rather than a specific operational project.)
  • APA Corporation (APA): Deliver total adjusted oil production growth of more than 10% for the year · outside the methodology's scope (financial: This is a production growth percentage target.)
  • APA Corporation (APA): Maintain an average of 17 drilling rigs in Egypt and five in the U.S · outside the methodology's scope (vague: Maintaining an average number of rigs is an ongoing operational state, not a specific, checkable end-point.)
  • APA Corporation (APA): Reach final investment decision on Block 58 · outside the methodology's scope (other: A final investment decision is a financial/strategic gate, not an operational execution step.)
  • APA Corporation (APA): Run a 12-rig program in Egypt · outside the methodology's scope (vague: Running a rig program is an ongoing operational activity rather than a specific, checkable project completion.)
  • APA Corporation (APA): Run an eight-rig program in the Permian Basin · outside the methodology's scope (vague: Running a rig program is an ongoing operational activity rather than a specific, checkable project completion.)
  • APA Corporation (APA): Achieve Egypt gross gas production of 540 MMCF per day · outside the methodology's scope (financial: This is a production volume target/guidance, which is a financial/performance metric.)
  • APA Corporation (APA): Achieve U.S. oil production of 121,000 barrels per day · outside the methodology's scope (financial: This is a production volume target/guidance, which is a financial/performance metric.)
  • APA Corporation (APA): Achieve Egypt gross gas production of 540-550 MMCF per day · outside the methodology's scope (financial: This is a production volume target/guidance, which is a financial/performance metric.)
  • APA Corporation (APA): Achieve U.S. oil production of 122,000 barrels per day · outside the methodology's scope (financial: This is a production volume target/guidance, which is a financial/performance metric.)
  • Axon Enterprise (AXON): Begin ramping Axon Body 3 camera shipments · outside the methodology's scope (vague: Ramping shipments is an ongoing process without a defined, checkable end point.)
  • Axon Enterprise (AXON): Publish the third responsibility report, the Force For Good report 2023 · outside the methodology's scope (accounting: Publishing a responsibility report is a routine corporate/accounting/disclosure event.)
  • Baker Hughes (BKR): Install up to 500 megawatts of geothermal power capacity in North America · outside the methodology's scope (vague: The commitment is a broad, long-term goal without a specific, checkable operational milestone.)
  • Bank Of America Corp. (BAC): Expire the exchange offers · outside the methodology's scope (other: This is a financial transaction/corporate action rather than an operational commitment.)
  • Baxter International (BAX): Launch more than 200 new products, geographic expansions and line extensions · outside the methodology's scope (vague: The commitment to launch 'more than 200' items is a broad, non-specific target rather than a single checkable operational event.)
  • Baxter International (BAX): Finalize the cost reduction program · outside the methodology's scope (vague: Cost reduction programs are often internal administrative/accounting restructurings rather than specific operational outputs.)
  • Baxter International (BAX): Complete the new operating model design process · outside the methodology's scope (vague: Internal process design is an administrative/accounting activity, not a specific operational output.)
  • Baxter International (BAX): Report against the Task Force on Climate-Related Disclosures (TCFD) framework · outside the methodology's scope (vague: Reporting against a framework is an ongoing process/accounting activity rather than a specific, one-time operational event.)
  • Baxter International (BAX): Report quarterly performance in line with the new operating model · outside the methodology's scope (financial: Reporting performance in line with a new model is a financial/accounting reporting activity, not a specific operational milestone.)
  • Baxter International (BAX): Implement an updated reporting framework · outside the methodology's scope (accounting: Updating a reporting framework is an accounting/administrative task.)
  • Becton Dickinson (BDX): Expand and upgrade manufacturing capacity and technology for pre-fillable syringes and advanced drug delivery systems · outside the methodology's scope (vague: This is a broad, multi-year investment plan without a specific, checkable operational end point.)
  • Biogen (BIIB): Obtain final analysis results for the BAN2401 clinical study · outside the methodology's scope (third_party: Obtaining results from a clinical study is often dependent on data analysis and external factors, and is not a direct operational output.)
  • Boston Scientific (BSX): Complete the acquisition of BTG PLC by the long stop date · outside the methodology's scope (assumption: A long stop date is a contractual deadline/assumption for the deal, not a firm commitment to close by that date.)
  • C.H. Robinson (CHRW): Reach a 15% year-over-year improvement in shipments per person per day by Q4 2023 · outside the methodology's scope (financial: This is a performance/efficiency target.)
  • Cadence Design Systems (CDNS): Complete analysis and record the income tax impact of the international operating structure realignment · outside the methodology's scope (accounting: This is an accounting/tax reporting task.)
  • Centene Corporation (CNC): Commence Medicaid managed care services in Pennsylvania · outside the methodology's scope (third_party: The commitment is contingent on regulatory approval and readiness review, making it a third-party dependency.)
  • Centene Corporation (CNC): Commence Medicaid managed care services in Nevada · outside the methodology's scope (third_party: The commitment is contingent on regulatory approval and readiness review, making it a third-party dependency.)
  • Centene Corporation (CNC): Commence the new three-year agreement for MississippiCAN managed care services · outside the methodology's scope (third_party: The commencement is explicitly contingent on regulatory approval.)
  • Centene Corporation (CNC): Finalize the 2014-2016 IHSS program reconciliation · outside the methodology's scope (accounting: Reconciliation is an accounting/financial process.)
  • Centene Corporation (CNC): Expire the exchange offers for WellCare Notes · outside the methodology's scope (accounting: This is an accounting/financial transaction related to debt/notes, not an operational commitment.)
  • Centene Corporation (CNC): Begin the expanded contract to serve as a coordinated care organization in Oregon · outside the methodology's scope (third_party: The commitment is explicitly contingent on third-party regulatory readiness review and negotiations.)
  • Centene Corporation (CNC): Extend the expiration date of the exchange offers and consent solicitations · outside the methodology's scope (accounting: This is an administrative/accounting step related to a financial offer.)
  • Centene Corporation (CNC): Operate Medicare Advantage plans in 1,249 counties across 33 states · outside the methodology's scope (vague: Operating in a number of counties is a general business activity/scale rather than a specific, checkable project milestone.)
  • Centene Corporation (CNC): Begin Mississippi Medicaid contract · outside the methodology's scope (third_party: The start of the contract is explicitly subject to the resolution of third-party protests.)
  • Centene Corporation (CNC): Begin California Medicaid contracts · outside the methodology's scope (third_party: The start of the contract is explicitly subject to the resolution of the protest process.)
  • Chevron Corp. (CVX): Achieve Permian production of approximately 125 thousand barrels of oil equivalent per day · outside the methodology's scope (financial: This is a production volume target, which is a performance metric.)
  • Cintas (CTAS): Incur transaction and integration expenses related to the G&K acquisition · outside the methodology's scope (financial: This is a financial projection of expenses rather than an operational milestone.)
  • Cintas (CTAS): Provide second quarter financial estimates · outside the methodology's scope (financial: This is a financial guidance/estimate, not an operational commitment.)
  • Citizens Financial Group (CFG): Upgrade the mobile and online banking platform to best-in-class in 2020 · outside the methodology's scope (vague: Upgrading to 'best-in-class' is a subjective, non-checkable goal.)
  • Coca Cola Co. (KO): Introduce more than 500 new products · outside the methodology's scope (vague: Broad portfolio goal without specific, checkable milestones.)
  • Coca Cola Co. (KO): Publish the 2019 Business & Sustainability Report · outside the methodology's scope (accounting: Publishing a sustainability report is a routine corporate reporting/accounting event.)
  • Cummins (CMI): Reach a 50 percent intensity reduction in water use at company facilities · outside the methodology's scope (vague: This is a long-term sustainability goal without a clear, immediate operational step.)
  • Delta Air Lines (DAL): Acquire aircraft with cash · outside the methodology's scope (vague: Acquiring aircraft with cash is a general financial/operational activity without a specific, checkable target or milestone.)
  • and 178 more in the file above.
Corrections
  • APA Corporation: deadline corrected from 2021-09-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Pentair: deadline corrected from 2017-03-31 to 2017-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Quanta Services: deadline corrected from 2018-09-30 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Southwest Airlines: deadline corrected from 2026-03-31 to 2026-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • United Airlines Holdings: deadline corrected from 2018-10-31 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • United Airlines Holdings: deadline corrected from 2023-03-31 to 2023-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

12 Oct 2026

  • 594added
  • 307outcomes recorded
  • 23withdrawn from publication
  • 2corrected
Withdrawn: Too vague to check (13), Financial forecast, not an operational deliverable (7), Outside the methodology's scope (3)
  • Chevron Corp. (CVX): Increase net production from the Gulf of America to 300,000 barrels of oil equivalent per day · outside the methodology's scope (financial: This is a production volume target/forecast, not a specific operational milestone.)
  • Cintas (CTAS): Sign and announce a definitive agreement with UniFirst · outside the methodology's scope (vague: Working towards signing an agreement is a process step, not a definitive operational commitment to complete the transaction.)
  • Delta Air Lines (DAL): Reduce planned capacity growth to flat year-on-year in the second half of 2025 · outside the methodology's scope (financial: This is a capacity growth target, which is a performance/financial metric.)
  • Delta Air Lines (DAL): Increase total destinations serviced from Austin to 30 · outside the methodology's scope (vague: Increasing destinations is a vague operational goal without a specific, checkable end-state definition.)
  • Equifax (EFX): Maintain flat pricing for Vantage 4.0 credit scores · outside the methodology's scope (financial: Maintaining flat pricing is a financial/pricing strategy rather than an operational output.)
  • Fastenal (FAST): Achieve weighted FASTBin and FASTVend device signings · outside the methodology's scope (financial: This is a sales/performance target for device signings.)
  • Ferguson Enterprises (FERG): Complete the review of the London Stock Exchange secondary listing · outside the methodology's scope (other: This is a corporate strategic review, not an operational delivery or launch.)
  • Fifth Third Bancorp (FITB): Have approximately 1,750 branches in its network · outside the methodology's scope (financial: This is a network size target/goal, which functions as a performance/scale target rather than a specific operational project.)
  • Honeywell Aerospace (HONA): Expand the number of multi-sourced parts · outside the methodology's scope (financial: This is a performance target (percentage increase) rather than a specific operational milestone.)
  • Honeywell Technologies (HON): Implement new segmentation and simplified structure for automation businesses · outside the methodology's scope (vague: Reorganization into segments is a structural/management change rather than a specific, checkable operational output.)
  • Huntington Ingalls Industries (HII): Achieve a 15% shipbuilding throughput improvement · outside the methodology's scope (vague: This is a performance improvement goal rather than a specific operational milestone.)
  • IMC Rare Earths Ltd (IMC): Publish an updated Mineral Resource estimate for the Itarantim project · outside the methodology's scope (vague: Publishing a resource estimate is a routine technical/corporate reporting activity, not a specific operational milestone.)
  • Netflix Inc. (NFLX): Be in production on more than 100 productions in the UK · outside the methodology's scope (vague: Being 'in production' on a portfolio of projects is a general operational state rather than a specific, checkable milestone.)
  • Netflix Inc. (NFLX): Release the Q4 2025 content slate, including the final season of Stranger Things · outside the methodology's scope (vague: Releasing a content slate is a routine corporate activity rather than a specific operational commitment.)
  • Oracle Corp. (ORCL): Introduce the new Oracle AI Database Cloud Infrastructure service at Oracle AI World · outside the methodology's scope (event: The commitment is to introduce a product at a conference/trade show.)
  • PNC Financial Services (PNC): Renovate 100% of PNC branches · outside the methodology's scope (vague: Renovating 100% of branches is a long-term, vague operational goal without a specific, checkable milestone.)
  • Regeneron Pharmaceuticals (REGN): Present final 26-week COURAGE Phase 2 obesity results at EASD meeting · outside the methodology's scope (event: Presenting at a conference is a routine corporate event.)
  • Sandisk Corp (SNDK): Bring BiCS8 technology to majority of bit production · outside the methodology's scope (financial: This is a production mix target related to output volume/share.)
  • Tenax Therapeutics, Inc. (TENX): Publish the LEVEL protocol design paper, primary publication and further analyses · outside the methodology's scope (vague: Publishing papers and analyses is a routine corporate activity without a single, clear, checkable end-point event.)
  • Veeva Systems (VEEV): Bring AI capabilities to Vault CRM during 2025 · outside the methodology's scope (vague: Bringing AI capabilities is a broad, non-specific product roadmap item.)
  • Veeva Systems (VEEV): Release new Veeva AI agents for clinical operations, regulatory, safety, quality, medical and commercial · outside the methodology's scope (vague: The commitment is too broad ('planned for 2026') without a specific, checkable end point or milestone.)
  • Veeva Systems (VEEV): Release additional Veeva AI agents across its other major application areas · outside the methodology's scope (vague: Releasing 'additional agents' is too vague to be a specific, checkable operational commitment.)
  • Walt Disney Co (DIS): Roughly triple the number of local original series on Disney+ · outside the methodology's scope (vague: This is a broad, open-ended plan to increase content over a long period without a specific, checkable end-point event.)
Corrections
  • Cummins: deadline corrected from 2017-09-30 to 2017-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • W. W. Grainger: deadline corrected from 2017-09-30 to 2017-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

11 Oct 2026

  • 315added
  • 149outcomes recorded
  • 1withdrawn from publication
  • 10corrected
Withdrawn: Outside the methodology's scope (1)
  • GH Research plc (GHRS): Present data from GH001-TRD-201 and GH001-BD-202 clinical trials in three posters at ECNP · outside the methodology's scope (event: Presenting posters at the ECNP conference is participation in a trade or scientific event, not an operational commitment.)
Corrections
  • Allegion: deadline corrected from 2018-03-31 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Amazon COM Inc.: deadline corrected from 2027-04-29 to 2027-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Cboe Global Markets: deadline corrected from 2020-06-30 to 2020-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Cboe Global Markets: deadline corrected from 2022-06-30 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Cboe Global Markets: deadline corrected from 2022-06-30 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Intel Corp.: deadline corrected from 2025-12-27 to 2025-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Intercontinental Exchange: deadline corrected from 2019-09-30 to 2019-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • PayPal: deadline corrected from 2026-02-25 to 2026-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • S&P Global: deadline corrected from 2018-04-30 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Willis Towers Watson: deadline corrected from 2019-09-30 to 2019-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

10 Oct 2026

  • 934added
  • 350outcomes recorded
  • 2corrected
Corrections
  • Elevance Health: deadline corrected from 2019-06-30 to 2019-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Incyte: deadline corrected from 2022-03-31 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

8 Oct 2026

  • 240added
  • 101outcomes recorded
  • 37confirmed
  • 49withdrawn from publication
Withdrawn: Financial forecast, not an operational deliverable (20), Too vague to check (15), Outside the methodology's scope (8), Depends on a third party, not the company (6)
  • 3M Co. (MMM): Reduce water use by 10% · outside the methodology's scope (financial: This is a percentage-based reduction target, which functions as a performance metric.)
  • 3M Co. (MMM): Reduce water use by 20% · outside the methodology's scope (financial: This is a percentage-based reduction target, which functions as a performance metric.)
  • AbbVie Inc. (ABBV): Add new indications for Rinvoq and Skyrizi · outside the methodology's scope (vague: Adding indications is a broad, ongoing strategic goal without a specific, checkable end point.)
  • Amazon COM Inc. (AMZN): Hold Prime Day in the second quarter · outside the methodology's scope (event: Holding a promotional event like Prime Day is a routine corporate event.)
  • Amazon COM Inc. (AMZN): Onboard 100,000 small and medium-sized businesses · outside the methodology's scope (vague: Onboarding a number of businesses is a general business plan/growth target rather than a specific operational event.)
  • Amazon COM Inc. (AMZN): Invest in safety projects and create collision prevention technology · outside the methodology's scope (financial: The commitment is framed primarily as a financial investment ($300 million) rather than a specific operational milestone.)
  • Amazon COM Inc. (AMZN): Power 100% of company activities with renewable energy · outside the methodology's scope (vague: This is a broad, long-term sustainability goal rather than a specific, checkable operational milestone.)
  • Amazon COM Inc. (AMZN): Cut recordable incident rates by 50% by 2025 · outside the methodology's scope (financial: This is a performance target (safety metric) rather than a specific operational project.)
  • Amazon COM Inc. (AMZN): Power all businesses with 100% renewable energy by 2025 · outside the methodology's scope (financial: This is a sustainability/performance target rather than a specific operational project.)
  • Amazon COM Inc. (AMZN): Bring one million Local Shops online by 2025 · outside the methodology's scope (vague: This is a broad, open-ended initiative rather than a specific, checkable operational project.)
  • Analog Devices (ADI): Achieve sustainability performance target · outside the methodology's scope (financial: Sustainability performance targets are typically treated as performance metrics rather than specific operational milestones.)
  • At&T Inc. (T): Grow the fiber subscriber base by more than 25% · outside the methodology's scope (financial: This is a growth target for a subscriber base, which is a financial/performance metric.)
  • At&T Inc. (T): Make vendor financing payments · outside the methodology's scope (financial: This is a financial payment/expenditure target.)
  • BioNexus Gene Lab Corp (BGLC): Close the licensing transaction with Ruanyun Edai Technology Inc · outside the methodology's scope (assumption: This is a termination deadline clause, not a commitment to close by that date.)
  • Boeing Co. (BA): Deliver fewer than half of 787s currently in inventory · outside the methodology's scope (vague: This is a negative target ('fewer than half') rather than a specific, checkable delivery milestone.)
  • Coca Cola Co. (KO): Double spending with minority-owned media companies in North America · outside the methodology's scope (vague: Doubling spending is a financial/budgetary target rather than a specific operational milestone.)
  • Coherent Corp. (COHR): Hold special meetings for shareholders to vote on the transaction · outside the methodology's scope (event: Holding a shareholder meeting is a routine corporate event.)
  • Coherent Corp. (COHR): Ramp silicon carbide substrate capacity and qualify a SiC epitaxial platform · outside the methodology's scope (vague: The commitment to ramp capacity and qualify a platform over 5 years is too open-ended and lacks a specific, checkable milestone.)
  • Duke Energy Corp. (DUK): Operate or purchase 16,000 megawatts of renewable energy capacity by 2025 · outside the methodology's scope (financial: This is a capacity target/performance goal rather than a specific operational project.)
  • First Solar (FSLR): Complete the sale of the U.S. project development and North American O&M businesses · outside the methodology's scope (financial: The text describes a financial gain from a sale rather than the operational act of completing the sale itself.)
  • General Motors Co (GM): Commercialize self-driving technology · outside the methodology's scope (vague: Commercializing self-driving technology is a broad, long-term strategic goal without a specific, checkable operational milestone.)
  • Intel Corp. (INTC): Ramp Intel 20A process technology · outside the methodology's scope (vague: Ramping a process technology is a continuous improvement process rather than a single, checkable event.)
  • International Business Machines Corp. (IBM): Reach 1,000-plus qubits in quantum computing · outside the methodology's scope (vague: A roadmap target for a technical capability (qubits) is a research/development goal rather than a specific operational commitment.)
  • Jpmorgan Chase & Co. (JPM): Integrate the Stress Capital Buffer into capital requirements · outside the methodology's scope (third_party: This relates to regulatory capital requirements and compliance, not an internal operational project.)
  • Lockheed Martin Corp. (LMT): Begin paying and administering retirement benefits for certain retirees and beneficiaries · outside the methodology's scope (third_party: The commitment is for Athene to perform the action, not the issuing company.)
  • Medtronic plc (MDT): Report fiscal year 2021 third quarter results · outside the methodology's scope (accounting: Reporting financial results is a routine accounting/financial disclosure event.)
  • Medtronic plc (MDT): Report fiscal year 2021 fourth quarter results · outside the methodology's scope (accounting: Reporting financial results is a routine accounting/financial disclosure event.)
  • Medtronic plc (MDT): Report fiscal year 2022 first quarter results · outside the methodology's scope (accounting: Reporting financial results is a routine accounting/financial disclosure event.)
  • Merck & Co., Inc. (MRK): Present full results from the KEYNOTE-581 trial · outside the methodology's scope (event: Presenting data at a conference is a routine corporate event.)
  • Merck & Co., Inc. (MRK): Achieve carbon neutrality in operations (Scopes 1 & 2 emissions) · outside the methodology's scope (vague: Carbon neutrality is a broad, long-term sustainability goal rather than a specific, checkable operational milestone.)
  • Nextera Energy Inc. (NEE): Operate Gulf Power as a separate division · outside the methodology's scope (vague: Continuing to operate as a division is a status quo maintenance, not a specific operational change or project.)
  • Nextera Energy Inc. (NEE): Begin a four-year rate plan · outside the methodology's scope (third_party: Proposing a rate plan requires regulatory approval, making it a third-party dependent event.)
  • Nextera Energy Inc. (NEE): Phase in new base rates for Florida Power & Light · outside the methodology's scope (financial: Adjusting base rates is a financial/regulatory process rather than an operational milestone.)
  • Nextera Energy Inc. (NEE): Request a Solar Base Rate Adjustment mechanism · outside the methodology's scope (third_party: Requesting a rate adjustment mechanism is a regulatory filing/process dependent on third-party approval.)
  • Pfizer Inc. (PFE): Supply EpiPen Auto-Injectors to Mylan under a supply agreement · outside the methodology's scope (vague: This describes an ongoing supply agreement rather than a specific, one-time operational commitment.)
  • Philip Morris International Inc. (PM): Close the tender offer period for Vectura Group plc shares · outside the methodology's scope (other: This is an administrative deadline for a tender offer.)
  • Philip Morris International Inc. (PM): Keep the offer for Vectura Group plc open for acceptance · outside the methodology's scope (other: This is an administrative deadline for a tender offer, not an operational launch or construction.)
  • Philip Morris International Inc. (PM): Launch ILUMA in additional markets · outside the methodology's scope (vague: The commitment is vague regarding specific markets and timing.)
  • Philip Morris International Inc. (PM): Submit ASPRIHALE® filing to the FDA · outside the methodology's scope (third_party: Submitting a filing for regulatory approval is a regulatory process.)
  • Philip Morris International Inc. (PM): Increase the number of markets where smoke-free products are available to 100 · outside the methodology's scope (financial: This is a market penetration target, which functions as a performance metric.)
  • Qualcomm Inc. (QCOM): Incorporate Arriver assets into the Snapdragon Ride ADAS solution · outside the methodology's scope (vague: The commitment is conditional on the close of a transaction and lacks a specific, checkable date or period for the integration itself.)
  • Tesla, Inc. (TSLA): Reach full production capacity at the Fremont plant · outside the methodology's scope (vague: Reaching 'full capacity' is a vague operational target without a specific, checkable definition.)
  • Turn Therapeutics Inc. (TTRX): Conduct FDA Type B meeting · outside the methodology's scope (third_party: An FDA meeting is a regulatory interaction/event, not a unilateral operational commitment.)
  • Tyler Technologies (TYL): End the rent relief program · outside the methodology's scope (financial: Ending a revenue-generating program is a financial/accounting matter.)
  • Tyler Technologies (TYL): End NIC's COVID-related initiatives · outside the methodology's scope (financial: Ending a revenue-generating initiative is a financial/accounting matter.)
  • US Bancorp (USB): Begin repurchasing common shares · outside the methodology's scope (financial: Share repurchases are a financial/capital allocation activity, not an operational one.)
  • Verizon Communications Inc. (VZ): Close the sale of Verizon Media to Apollo funds · outside the methodology's scope (assumption: The company explicitly frames this as a planning assumption.)
  • W&T Offshore Inc. (WTI): Redetermine the borrowing base · outside the methodology's scope (accounting: Redetermining a borrowing base is a routine financial/accounting process.)
  • Workday, Inc. (WDAY): Unveil multiple generative AI capabilities at Workday Rising · outside the methodology's scope (event: Unveiling at a conference is a routine corporate event.)

7 Oct 2026

  • 124added
  • 73outcomes recorded
  • 42confirmed
  • 48withdrawn from publication
Withdrawn: Too vague to check (20), Financial forecast, not an operational deliverable (17), Depends on a third party, not the company (5), Outside the methodology's scope (5), Accounting or internal process (1)
  • 60 Degrees Pharmaceuticals, Inc. (SXTP): Submit a request for a pre-sNDA meeting with the FDA · outside the methodology's scope (third_party: Requesting a meeting with the FDA is a regulatory interaction.)
  • 60 Degrees Pharmaceuticals, Inc. (SXTP): Conduct pre-sNDA meeting with the FDA · outside the methodology's scope (third_party: A meeting with the FDA is a regulatory interaction/process, not a unilateral operational commitment.)
  • Advanced Micro Devices Inc. (AMD): Increase energy efficiency of processors running AI training and high performance computing applications 30x · outside the methodology's scope (vague: This is a long-term performance target/goal rather than a specific operational project.)
  • Allied Gold Corp (AAUC): Conduct a field review at Agu and Ahushu · outside the methodology's scope (vague: A 'field review' is a general activity without a clear, checkable end-product or outcome.)
  • Altria Group, Inc. (MO): Issue the 2020-2021 Protect the Environment corporate responsibility report · outside the methodology's scope (other: Issuing a corporate responsibility report is a routine corporate communication/event.)
  • At&T Inc. (T): Serve 75% of network footprint via fiber and 5G · outside the methodology's scope (vague: This is a broad strategic target for network coverage rather than a specific operational project.)
  • Black Hills Corp. (BKH): File the Wyoming transmission expansion Certificate of Public Convenience and Necessity · outside the methodology's scope (third_party: Filing a CPCN is a regulatory filing process.)
  • Boeing Co. (BA): Deliver 400-450 737 airplanes · outside the methodology's scope (financial: This is a delivery volume target/forecast, not a specific operational milestone.)
  • Bristol Myers Squibb Co. (BMY): Achieve ≥ 25% new clinical trial sites in diverse metro areas · outside the methodology's scope (financial: This is a performance target/metric rather than a specific operational project completion.)
  • Bristol Myers Squibb Co. (BMY): Establish science-based emissions reduction targets · outside the methodology's scope (vague: Establishing targets is a planning activity, not a specific operational output.)
  • CVS Health Corp (CVS): Expand the network to over 300 centers · outside the methodology's scope (financial: This is a target for the number of centers, which is a performance/growth metric.)
  • Duke Energy Corp. (DUK): Implement permanent total Year 1 rates · outside the methodology's scope (third_party: The commitment is subject to regulatory approval (NCUC), making it a third-party dependency.)
  • F5, Inc. (FFIV): Provide specific information on office locations · outside the methodology's scope (vague: Providing information is a vague corporate communication task, not a specific operational milestone.)
  • F5, Inc. (FFIV): Begin office consolidation · outside the methodology's scope (vague: Office consolidation is a broad, ongoing process without a specific, checkable end point.)
  • Gen Digital (GEN): Make the Lender Presentation available on company websites · outside the methodology's scope (other: This is a routine administrative task (posting a presentation) rather than a significant operational commitment.)
  • Gen Digital (GEN): Publish the press release on the company website · outside the methodology's scope (other: This is a routine administrative task (posting a press release) rather than a significant operational commitment.)
  • Gen Digital (GEN): Hold the Court Hearing to sanction the Scheme · outside the methodology's scope (third_party: Court hearings are legal/third-party processes.)
  • Gen Digital (GEN): Reach the Long Stop Date for the merger · outside the methodology's scope (assumption: A 'Long Stop Date' is a contractual deadline/assumption for a merger, not an operational commitment.)
  • Intel Corp. (INTC): Regain transistor and power performance leadership · outside the methodology's scope (vague: Regaining 'leadership' is a subjective, non-checkable performance goal.)
  • Inventiva S.A. (IVA): Present Phase 2b clinical results at AASLD The Liver Meeting 2026 · outside the methodology's scope (event: Presenting at a conference is a routine corporate event.)
  • Johnson & Johnson (JNJ): Maintain current pay, benefits and retirement programs for New Consumer Health Company employees · outside the methodology's scope (vague: Maintaining benefits is a general policy continuation rather than a specific operational project.)
  • Johnson & Johnson (JNJ): Achieve 100% renewable electricity for all sites in the United States, Canada, and Europe · outside the methodology's scope (vague: This is a long-term sustainability goal/target rather than a specific operational project milestone.)
  • Johnson & Johnson (JNJ): Complete the exclusion of external third-party regulatory and consulting costs related to EU MDR · outside the methodology's scope (accounting: This relates to accounting treatment and exclusion of costs.)
  • Kamada Ltd. (KMDA): Market at least 12 biosimilar products · outside the methodology's scope (vague: This is a long-term strategic goal/portfolio target rather than a specific, checkable operational project.)
  • Lockheed Martin Corp. (LMT): Deliver 147-153 F-35 aircraft per year · outside the methodology's scope (financial: This is a production/delivery volume target, which functions as a performance target.)
  • Lockheed Martin Corp. (LMT): Achieve delivery target of 156 F-35 aircraft · outside the methodology's scope (financial: This is a specific delivery volume target, which functions as a performance target.)
  • Mcdonalds Corp. (MCD): Open over 1,300 net new restaurants · outside the methodology's scope (financial: Opening new restaurants is a growth/expansion target, which is a performance metric.)
  • Nextera Energy Inc. (NEE): Place into service new renewables and storage projects · outside the methodology's scope (financial: This is a capacity target/forecast for new projects.)
  • NXP Semiconductors (NXPI): Reduce carbon emissions by 35 percent · outside the methodology's scope (vague: Reducing carbon emissions is a broad, long-term sustainability goal without a specific operational milestone.)
  • NXP Semiconductors (NXPI): Recycle 60 percent of water · outside the methodology's scope (vague: Recycling water is a broad, long-term sustainability goal without a specific operational milestone.)
  • NXP Semiconductors (NXPI): Increase renewable energy use by 50 percent · outside the methodology's scope (vague: Increasing renewable energy use is a broad, long-term sustainability goal without a specific operational milestone.)
  • NXP Semiconductors (NXPI): Achieve a 90 percent waste recycling rate · outside the methodology's scope (vague: Achieving a recycling rate is a broad, long-term sustainability goal without a specific operational milestone.)
  • Philip Morris International Inc. (PM): Disclose historical financial information based on the new regional structure · outside the methodology's scope (accounting: This is a routine financial reporting and accounting disclosure task.)
  • Philip Morris International Inc. (PM): Become a predominantly smoke-free company · outside the methodology's scope (vague: The goal to be a 'predominantly smoke-free company' is a strategic ambition rather than a specific, checkable operational milestone.)
  • ServiceNow, Inc. (NOW): Skill one million people on its platform · outside the methodology's scope (vague: Skilling people is a broad, non-specific initiative without a clear, checkable operational definition of 'skill'.)
  • Starbucks Corp. (SBUX): Increase pay for retail partners with two or more years of service · outside the methodology's scope (financial: This is a pay increase, which is a financial/compensation target rather than an operational milestone.)
  • Starbucks Corp. (SBUX): Support chronic homelessness in the greater Seattle area through programming and partnerships · outside the methodology's scope (vague: Supporting homelessness through programming is a broad, non-specific initiative.)
  • Starbucks Corp. (SBUX): Achieve BIPOC representation of at least 30 percent at corporate levels and 40 percent at retail roles · outside the methodology's scope (financial: This is a diversity target/metric, which falls under performance targets.)
  • T-Mobile US, Inc. (TMUS): Substantially complete the merger integration · outside the methodology's scope (vague: Integration completion is a broad, non-specific operational milestone.)
  • Union Pacific Corp. (UNP): Achieve full year reported operating ratio · outside the methodology's scope (financial: This is a financial performance target (operating ratio).)
  • Union Pacific Corp. (UNP): Achieve full year carload growth · outside the methodology's scope (financial: This is a financial performance target (carload growth).)
  • Union Pacific Corp. (UNP): Execute capital spending · outside the methodology's scope (financial: This is a financial spending target, not a specific operational milestone.)
  • Union Pacific Corp. (UNP): Reevaluate progress and targets · outside the methodology's scope (vague: Reevaluating progress and targets is a management process, not a specific operational output.)
  • Unitedhealth Group Inc. (UNH): Serve 600,000 new patients under value-based care arrangements · outside the methodology's scope (financial: This is a patient volume target, which functions as a performance/business metric.)
  • Verizon Communications Inc. (VZ): Add 550,000 Fios Open for Sale locations · outside the methodology's scope (financial: This is a volume target for sales/service locations, which is a performance metric.)
  • Verizon Communications Inc. (VZ): Reach 50% of sites on Verizon Fiber · outside the methodology's scope (vague: This is a broad network coverage target rather than a specific operational project.)
  • Walmart Inc. (WMT): Service roughly 65% of stores with automation · outside the methodology's scope (financial: This is a performance target/metric regarding service coverage percentage.)
  • Walmart Inc. (WMT): Move approximately 55% of fulfillment center volume through automated facilities · outside the methodology's scope (financial: This is a performance target/metric regarding volume percentage.)

6 Oct 2026

  • 156added
  • 68outcomes recorded
  • 28withdrawn from publication
  • 2corrected
Withdrawn: Depends on a third party, not the company (9), Outside the methodology's scope (8), Too vague to check (5), Financial forecast, not an operational deliverable (5), Accounting or internal process (1)
  • Acadia Pharmaceuticals Inc. (ACAD): Hold a pre-New Drug Application meeting with the U.S. FDA · outside the methodology's scope (third_party: A meeting with the FDA is a regulatory interaction/event involving a third party.)
  • Adma Biologics, Inc. (ADMA): Achieve FDA approval for ten BioCenters locations · outside the methodology's scope (third_party: FDA approval is a third-party regulatory action, not an internal operational commitment.)
  • Adma Biologics, Inc. (ADMA): Operate ten or more FDA-licensed plasma collection centers · outside the methodology's scope (third_party: The commitment is contingent on FDA licensing, which is a third-party regulatory action.)
  • Adma Biologics, Inc. (ADMA): Achieve plasma supply self-sufficiency · outside the methodology's scope (vague: Achieving 'self-sufficiency' is an open-ended goal without a clear, checkable operational milestone.)
  • Adma Biologics, Inc. (ADMA): Achieve FDA approval for 10 or more plasma collection centers · outside the methodology's scope (third_party: FDA approval is a third-party regulatory action, not an internal operational commitment.)
  • Adma Biologics, Inc. (ADMA): Have 10 or more plasma collection facilities FDA-licensed · outside the methodology's scope (third_party: The commitment relies on FDA licensing, which is a third-party regulatory action.)
  • Aldeyra Therapeutics, Inc. (ALDX): Hold a Type B Pre-NDA meeting with the FDA · outside the methodology's scope (third_party: Meeting with the FDA is a regulatory interaction/third-party event.)
  • Bank Of America Corp. (BAC): Replace USD LIBOR CMS Rate with USD CMS Replacement for Annex 2 instruments · outside the methodology's scope (other: This is a contractual/legal transition of financial terms, not an operational commitment.)
  • Bank Of America Corp. (BAC): Calculate interest rates for Annex 1 USD LIBOR CMS Instruments using fallback provisions · outside the methodology's scope (other: This is a contractual/legal calculation methodology change, not an operational commitment.)
  • Benitec Biopharma Inc. (BNTC): Present interim clinical results from the BB-301 Phase 1b/2a study · outside the methodology's scope (event: Presenting at a conference is a routine corporate event.)
  • Corcept Therapeutics Inc. (CORT): Present results of Phase 2 study at the AASLD meeting · outside the methodology's scope (event: Presenting at a conference is a routine corporate event.)
  • Corcept Therapeutics Inc. (CORT): Meet with the FDA regarding proposed path forward · outside the methodology's scope (third_party: Meeting with the FDA is a regulatory interaction/process, not a unilateral operational commitment.)
  • CVS Health Corp (CVS): Complete the enterprise-wide restructuring program · outside the methodology's scope (vague: Restructuring programs are often vague corporate initiatives without a clear, checkable end-state.)
  • Dell Technologies Inc. (DELL): Publish the fiscal year 2023 ESG report · outside the methodology's scope (accounting: Publishing a report is an administrative/accounting task, not an operational commitment.)
  • ELI Lilly & Co (LLY): Execute multiple new medicine product launches · outside the methodology's scope (vague: The commitment to 'multiple launches' is too vague without specific product names or counts.)
  • Endovia Health Sciences, Inc. (EDVA): Launch CannEpil for veterinary use · outside the methodology's scope (third_party: The launch is explicitly subject to regulatory approval, making it dependent on a third party.)
  • Eos Energy Enterprises, Inc. (EOSE): Achieve 800 MWh manufacturing capacity at the Turtle Creek facility · outside the methodology's scope (financial: This is a capacity target linked to capital expenditure, often treated as a performance/growth target.)
  • ImmunityBio, Inc. (IBRX): Advance PD-L1 t-haNK manufacturing to 500-liter scale · outside the methodology's scope (vague: Advancing manufacturing scale is an ongoing process without a clear, checkable end point.)
  • Intel Corp. (INTC): Achieve five process nodes in four years · outside the methodology's scope (vague: Achieving process nodes is a long-term strategic goal rather than a single checkable operational event.)
  • Intuit Inc. (INTU): Provide a TurboTax federal tax unit comparison · outside the methodology's scope (other: Providing a data comparison in an earnings release is a routine corporate disclosure/event.)
  • Larimar Therapeutics, Inc. (LRMR): Attend the scheduled Type C meeting with the FDA · outside the methodology's scope (third_party: Attending a meeting with the FDA is a regulatory interaction.)
  • Mcdonalds Corp. (MCD): Expand the global restaurant network to 50,000 locations · outside the methodology's scope (financial: This is a growth target (number of locations), which functions as a performance/financial target.)
  • PTC Inc. (PTC): Close the acquisition of PTC · outside the methodology's scope (being_acquired: The company is the one being acquired, so this belongs to the buyer's record.)
  • Replimune Group, Inc. (REPL): Present updated RP2 monotherapy and combination data at SITC · outside the methodology's scope (event: Presenting data at a conference (SITC) is an event/conference participation.)
  • Replimune Group, Inc. (REPL): Present the Phase 2 development plan for RP2/3 · outside the methodology's scope (event: Presenting a development plan is a routine corporate/investor event.)
  • Seven Hills Realty Trust (SEVN): Receive repayment of the Carlsbad, California office loan · outside the methodology's scope (financial: Receiving loan repayment is a financial event, not an operational commitment.)
  • US Bancorp (USB): Issue notices regarding Term SOFR transition for DTC-held instruments · outside the methodology's scope (other: Issuing notices is a routine administrative/legal communication, not an operational commitment.)
  • US Bancorp (USB): Transition outstanding LIBOR-linked securities to Term SOFR · outside the methodology's scope (other: This is a contractual/legal transition of financial instruments, not an operational commitment.)
Corrections
  • Nvidia Corp.: deadline corrected from 2024-03-31 to 2024-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Nvidia Corp.: deadline corrected from 2024-06-30 to 2024-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

5 Oct 2026

  • 148added
  • 66outcomes recorded
  • 35confirmed
  • 46withdrawn from publication
  • 1corrected
Withdrawn: Depends on a third party, not the company (14), Outside the methodology's scope (14), Too vague to check (10), Financial forecast, not an operational deliverable (7), Accounting or internal process (1)
  • Abeona Therapeutics Inc. (ABEO): Hold pre-IND meetings with the FDA for ophthalmic programs · outside the methodology's scope (third_party: Meetings with the FDA are subject to the regulator's schedule and approval.)
  • Abeona Therapeutics Inc. (ABEO): Present additional VIITAL study data at the International Societies for Investigative Dermatology Meeting · outside the methodology's scope (event: Presenting data at a conference is considered a routine corporate event.)
  • Abeona Therapeutics Inc. (ABEO): Present new preclinical data at a scientific congress · outside the methodology's scope (event: Presenting data at a scientific congress is considered a routine corporate event.)
  • Adma Biologics, Inc. (ADMA): Ensure all ten BioCenters are FDA-licensed · outside the methodology's scope (third_party: FDA licensing is a regulatory approval process, not an internal operational commitment.)
  • Adma Biologics, Inc. (ADMA): Obtain FDA licensure for a total of 10 plasma collection centers · outside the methodology's scope (third_party: Obtaining FDA licensure is a regulatory approval/decision by a third party.)
  • Aldeyra Therapeutics, Inc. (ALDX): Hold a pre-NDA meeting for ADX-2191 for primary vitreoretinal lymphoma · outside the methodology's scope (third_party: Meeting with the FDA is a regulatory interaction/third-party event.)
  • Aldeyra Therapeutics, Inc. (ALDX): Conduct pre-NDA meeting with the FDA for ADX-2191 · outside the methodology's scope (event: A pre-NDA meeting is a routine regulatory interaction/event.)
  • Aldeyra Therapeutics, Inc. (ALDX): Hold a Type C meeting with the FDA regarding Proliferative Vitreoretinopathy clinical development · outside the methodology's scope (third_party: Meeting with the FDA is a regulatory interaction/third-party event.)
  • Aldeyra Therapeutics, Inc. (ALDX): Discuss completion of clinical development for ADX-2191 with the FDA · outside the methodology's scope (third_party: Meeting with the FDA is a regulatory interaction/third-party event.)
  • Aldeyra Therapeutics, Inc. (ALDX): Launch ADX-2191 in the United States · outside the methodology's scope (third_party: The commitment is contingent on FDA approval, which is a third-party action.)
  • Alignment Healthcare, Inc. (ALHC): Execute planned market expansions · outside the methodology's scope (vague: Market expansion is a broad strategic goal, and the commitment is explicitly subject to regulatory approval.)
  • AST SpaceMobile, Inc. (ASTS): Decrease total and adjusted operating expenses · outside the methodology's scope (financial: This is a financial target regarding operating expenses.)
  • Baidu, Inc. (BIDU): Remove the stock marker 'S' from stock short names on the Hong Kong Stock Exchange · outside the methodology's scope (accounting: This is a corporate/administrative action regarding stock listing markers, not an operational commitment.)
  • Baidu, Inc. (BIDU): Complete the voluntary conversion to a dual-primary listing in Hong Kong · outside the methodology's scope (third_party: The commitment is contingent upon third-party approvals from shareholders and the Hong Kong Stock Exchange.)
  • Banc Of California, Inc. (BANC): Hold stockholder meetings · outside the methodology's scope (event: Holding stockholder meetings is a routine corporate event.)
  • Beam Therapeutics Inc. (BEAM): Share updates on next-generation allogeneic strategies · outside the methodology's scope (vague: Sharing updates is a vague communication activity, not a specific operational milestone.)
  • Beam Therapeutics Inc. (BEAM): Present data on multiple patients from the BEACON trial · outside the methodology's scope (event: Presenting data is typically considered a conference or routine corporate event.)
  • Capricor Therapeutics, Inc. (CAPR): Present 24-month HOPE-2 open label extension data · outside the methodology's scope (event: Presenting data is a routine corporate event.)
  • Capricor Therapeutics, Inc. (CAPR): Present 24-month follow-up data from HOPE-2 OLE · outside the methodology's scope (event: Presenting data at a conference or meeting is considered a routine corporate event.)
  • Capricor Therapeutics, Inc. (CAPR): Submit data from the HOPE-2-OLE study at a medical meeting · outside the methodology's scope (event: Submitting data at a medical meeting is a conference/event activity.)
  • Disc Medicine, Inc. (IRON): Present interim data from the BEACON study at the EHA Congress · outside the methodology's scope (event: Presenting data at a conference is a routine corporate event.)
  • Disc Medicine, Inc. (IRON): Present BEACON trial data at ASH 2023 · outside the methodology's scope (event: Presenting at a conference is a routine corporate event.)
  • Disc Medicine, Inc. (IRON): Present DISC-0974 NDD-CKD trial data at ASH 2023 · outside the methodology's scope (event: Presenting at a conference is a routine corporate event.)
  • Enerflex Ltd. (EFXT): Incur investments in ES facilities and capabilities · outside the methodology's scope (vague: Incurring investments is a financial activity, not a specific operational milestone.)
  • Eos Energy Enterprises, Inc. (EOSE): Grow American workforce to nearly one thousand green-collar careers · outside the methodology's scope (vague: Workforce growth targets are generally considered vague or performance-related rather than specific operational tasks.)
  • Fuelcell Energy Inc. (FCEL): Achieve an annualized production rate of 45 to 50 MW · outside the methodology's scope (financial: This is a production rate target, which functions as a performance/financial metric.)
  • Hyliion Holdings Corp. (HYLN): Ready the day cab version of the Hypertruck ERX platform · outside the methodology's scope (vague: Being 'ready' is a vague, non-specific operational target.)
  • Larimar Therapeutics, Inc. (LRMR): Attend a meeting with the FDA regarding the CTI-1601 Phase 2 trial · outside the methodology's scope (third_party: Attending a meeting with the FDA is dependent on the regulator's schedule.)
  • Larimar Therapeutics, Inc. (LRMR): Provide an update on the next steps for the CTI-1601 program · outside the methodology's scope (vague: Providing an update is an open-ended communication, not a specific operational milestone.)
  • Myriad Genetics Inc. (MYGN): Complete over 600 electronic health record integrations · outside the methodology's scope (vague: This is a broad, open-ended scaling goal rather than a specific, checkable operational milestone.)
  • Myriad Genetics Inc. (MYGN): Pay the second installment of the Ravgen litigation settlement · outside the methodology's scope (financial: This is a payment obligation related to a legal settlement, which is a financial commitment.)
  • Myriad Genetics Inc. (MYGN): Pay the third installment of the Ravgen litigation settlement · outside the methodology's scope (financial: This is a payment obligation related to a legal settlement, which is a financial commitment.)
  • New Fortress Energy Inc. (NFE): Add liquefaction capacity via Fast LNG units · outside the methodology's scope (financial: The commitment is framed as adding capacity (a performance/output metric) rather than a specific construction milestone.)
  • Powell Max Ltd (PMAX): End the private placement offering period · outside the methodology's scope (financial: This is a financial offering period, not an operational commitment.)
  • Replimune Group, Inc. (REPL): Provide an update on the RP2/3 Phase 2 development plans · outside the methodology's scope (vague: Providing an update on development plans is vague and lacks a concrete operational action.)
  • Replimune Group, Inc. (REPL): Provide update on the RP2/3 program · outside the methodology's scope (vague: Providing an 'update' is too vague and lacks a specific, checkable operational action.)
  • SELLAS Life Sciences Group, Inc. (SLS): Present clinical data at the 2022 American Society of Hematology meeting · outside the methodology's scope (event: Presenting clinical data at a meeting is an event.)
  • SELLAS Life Sciences Group, Inc. (SLS): Present final data from the GPS and pembrolizumab combination study · outside the methodology's scope (event: Presenting data at a medical conference is considered a routine corporate event.)
  • SELLAS Life Sciences Group, Inc. (SLS): Hold the next routine IDMC meeting for the REGAL study · outside the methodology's scope (event: Attending a routine committee meeting is a corporate event.)
  • Unicycive Therapeutics, Inc. (UNCY): Request a pre-IND meeting with the FDA · outside the methodology's scope (third_party: Requesting a meeting with the FDA is a regulatory interaction.)
  • Unicycive Therapeutics, Inc. (UNCY): Launch Renazorb in the United States · outside the methodology's scope (vague: The commitment is contingent on regulatory approval, making the launch date speculative rather than a firm commitment.)
  • uniQure N.V. (QURE): Complete safety review of AMT-130 higher-dose procedures · outside the methodology's scope (vague: A safety review is an internal process/assessment rather than a clear operational milestone.)
  • uniQure N.V. (QURE): Complete pre-approval site inspections for etranacogene dezaparvovec · outside the methodology's scope (third_party: Pre-approval site inspections are conducted by regulators, not the company.)
  • uniQure N.V. (QURE): Meet with the FDA to review AMT-130 data · outside the methodology's scope (third_party: Meeting with the FDA is a regulatory interaction/third-party event.)
  • uniQure N.V. (QURE): Conduct regulatory interactions to discuss AMT-130 data and development pathways · outside the methodology's scope (third_party: Regulatory interactions are dependent on the regulator's schedule and participation.)
  • uniQure N.V. (QURE): Hold regulatory interactions to discuss data from the U.S. and EU studies · outside the methodology's scope (third_party: Regulatory interactions are dependent on the regulator's schedule and participation.)
Corrections
  • RTX Corp: deadline corrected from 2023-09-15 to 2023-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

4 Oct 2026

  • 53added
  • 38outcomes recorded
  • 35confirmed
  • 1corrected
Corrections
  • Unicycive Therapeutics, Inc.: removed 1 version(s) taken from the same announcement · statements in one document are separate milestones, not a later restatement

3 Oct 2026

  • 209added
  • 96outcomes recorded
  • 39confirmed
  • 56withdrawn from publication
  • 2corrected
Withdrawn: Depends on a third party, not the company (24), Too vague to check (16), Financial forecast, not an operational deliverable (8), Outside the methodology's scope (8)
  • Abeona Therapeutics Inc. (ABEO): Fund operations into the first quarter of 2025 · outside the methodology's scope (financial: This is a statement about cash runway and financial liquidity, not an operational milestone.)
  • Adma Biologics, Inc. (ADMA): Advance pre-clinical work for the S. pneumonia program · outside the methodology's scope (vague: Advancing pre-clinical work is an open-ended activity with no defined, checkable end point.)
  • Aldeyra Therapeutics, Inc. (ALDX): Conduct a Type C meeting with the FDA regarding reproxalap · outside the methodology's scope (third_party: Conducting a meeting with the FDA is a regulatory interaction dependent on the regulator.)
  • Alignment Healthcare, Inc. (ALHC): Reduce inpatient admissions per thousand by 35% · outside the methodology's scope (financial: This is a performance/operational target (reduction in admissions), not a specific project milestone.)
  • Beam Therapeutics Inc. (BEAM): Present initial results from the BEACON clinical study of BEAM-101 · outside the methodology's scope (event: Presenting data at a conference is a routine corporate event.)
  • Beam Therapeutics Inc. (BEAM): Present preclinical data for ESCAPE in a Rhesus autologous transplantation model · outside the methodology's scope (event: Presenting data at a conference is a routine corporate event.)
  • Beam Therapeutics Inc. (BEAM): Present data on the impact of BEAM-101 treatment on red blood cell hemoglobin expression · outside the methodology's scope (event: Presenting data at a conference is a routine corporate event.)
  • Beneficient (BENF): Complete the Public Stockholder Enhancement Transactions · outside the methodology's scope (third_party: The closing is subject to third-party stockholder and regulatory approvals.)
  • Bloom Energy Corp (BE): Deploy the company's energy solution at GW scale · outside the methodology's scope (vague: Deploying a solution at scale is a general business plan without a specific, checkable end point.)
  • Capricor Therapeutics, Inc. (CAPR): Request a meeting with the FDA · outside the methodology's scope (third_party: Requesting a meeting with the FDA is a regulatory interaction dependent on the regulator's schedule and approval.)
  • Capricor Therapeutics, Inc. (CAPR): Attend a Type-B clinical FDA meeting · outside the methodology's scope (third_party: Meeting with the FDA is a regulatory interaction/third-party event.)
  • Capricor Therapeutics, Inc. (CAPR): Announce the outcome of the pre-BLA meeting · outside the methodology's scope (third_party: Announcing the outcome of a regulatory meeting is dependent on the regulator's process.)
  • Capricor Therapeutics, Inc. (CAPR): Finalize the definitive agreement with Nippon Shinyaku · outside the methodology's scope (third_party: Finalizing a definitive agreement with a partner is a negotiation/third-party process, not a unilateral operational commitment.)
  • Capricor Therapeutics, Inc. (CAPR): Present additional 3-year data from the HOPE-2 OLE study · outside the methodology's scope (event: Presenting data at a medical meeting is a routine corporate event.)
  • CareTrust REIT, Inc. (CTRE): Close the acquisition of one completed and operating home · outside the methodology's scope (third_party: The closing is contingent on regulatory approval, which is a third-party action.)
  • Corcept Therapeutics Inc. (CORT): Present CATALYST prevalence phase results at the American Diabetes Association’s 84th Scientific Sessions · outside the methodology's scope (event: Presenting results at a scientific conference is an event.)
  • Disc Medicine, Inc. (IRON): Conduct regulatory interactions to define optimal registrational endpoints for EPP · outside the methodology's scope (third_party: Regulatory interactions are defined as third-party/regulatory actions.)
  • Disc Medicine, Inc. (IRON): Provide additional data updates for DISC-0974 · outside the methodology's scope (vague: Providing 'additional data updates' is too vague to be a specific, checkable milestone.)
  • Disc Medicine, Inc. (IRON): Hold an End of Phase 2 meeting for bitopertin in EPP · outside the methodology's scope (third_party: An 'End of Phase 2 meeting' is a regulatory interaction/meeting with the FDA, which is a third-party process.)
  • Disc Medicine, Inc. (IRON): Provide an update on regulatory interactions for bitopertin and DISC-0974 · outside the methodology's scope (vague: Providing an update on regulatory interactions is a vague corporate communication, not a specific operational milestone.)
  • Disc Medicine, Inc. (IRON): Interact with regulators to determine the optimal Phase 2 study design for DISC-0974 · outside the methodology's scope (third_party: Interacting with regulators to determine study design is a third-party regulatory process.)
  • Disc Medicine, Inc. (IRON): Provide update on NDA submission plans for bitopertin · outside the methodology's scope (vague: Providing an 'update' on plans is a vague corporate communication, not a specific operational action.)
  • Emergent BioSolutions Inc. (EBS): Supply BioThrax vaccine to the U.S. Department of Defense · outside the methodology's scope (vague: This describes a multi-year contract duration rather than a specific operational commitment to deliver by a date.)
  • Eos Energy Enterprises, Inc. (EOSE): Achieve power density of 695 kWh for Eos Z3 Cube · outside the methodology's scope (financial: This is a performance target (power density/kWh) rather than a specific operational milestone.)
  • Eos Energy Enterprises, Inc. (EOSE): Increase Eos Z3 Cube power density to 800 kWh · outside the methodology's scope (financial: This is a performance target (power density/kWh) rather than a specific operational milestone.)
  • Eos Energy Enterprises, Inc. (EOSE): Close the loan with the Department of Energy's Loan Programs Office · outside the methodology's scope (third_party: Closing a loan with a government entity is dependent on the third party's approval and process.)
  • Eos Energy Enterprises, Inc. (EOSE): Draw the remaining tranche of funding from Cerberus · outside the methodology's scope (financial: This is a financial transaction (drawing funding) contingent on financial milestones.)
  • Eos Energy Enterprises, Inc. (EOSE): Achieve the next Cerberus milestones · outside the methodology's scope (vague: The commitment to 'achieve milestones' is vague and dependent on external funding conditions.)
  • Eos Energy Enterprises, Inc. (EOSE): Achieve operational milestones required for the delayed draw term loan · outside the methodology's scope (vague: Achieving 'operational milestones' is too vague and lacks a specific, checkable end point.)
  • Ford Motor Co. (F): Extend the Ford Power Promise program for new 2026 Mustang Mach-E customers · outside the methodology's scope (already_done: The text states the program 'has been extended', implying the action is already complete.)
  • Freeport-Mcmoran Inc. (FCX): Reach 80% of capacity at the Grasberg Block Cave · outside the methodology's scope (financial: Capacity utilization targets are generally considered performance or operational capacity metrics rather than specific project milestones.)
  • Freeport-Mcmoran Inc. (FCX): Reach full capacity at the Grasberg Block Cave · outside the methodology's scope (financial: Reaching full capacity is a performance/operational target rather than a specific project completion.)
  • Fuelcell Energy Inc. (FCEL): Provide baseload power supply for data centers · outside the methodology's scope (vague: Providing power is a general business activity without a specific, checkable project completion point.)
  • Hyliion Holdings Corp. (HYLN): Share further information about the JEC collaboration · outside the methodology's scope (vague: Sharing information is an open-ended communication plan with no defined operational end point.)
  • Larimar Therapeutics, Inc. (LRMR): Provide update on OLE study data and development program · outside the methodology's scope (vague: Providing an 'update' is too vague to be a specific, checkable milestone.)
  • LENZ Therapeutics, Inc. (LENZ): Close the merger with LENZ Therapeutics · outside the methodology's scope (being_acquired: The company is being acquired; this is a merger closing event.)
  • LENZ Therapeutics, Inc. (LENZ): Present Phase 3 CLARITY study data at a Key Opinion Leader event · outside the methodology's scope (event: Presenting data at a conference or KOL event is considered a routine corporate event.)
  • Myriad Genetics Inc. (MYGN): Launch multiple differentiated tests in prenatal and oncology · outside the methodology's scope (vague: The commitment to launch multiple tests is too broad and lacks a specific, checkable end point for each.)
  • Replimune Group, Inc. (REPL): Attend pre-BLA meeting with the FDA · outside the methodology's scope (third_party: Attending a regulatory meeting is a third-party interaction/event.)
  • TransMedics Group, Inc. (TMDX): Achieve 10,000 OCS transplant cases per year in the U.S · outside the methodology's scope (financial: This is a performance/volume target rather than a specific operational project completion.)
  • Unicycive Therapeutics, Inc. (UNCY): Request a meeting with the FDA regarding UNI-494 · outside the methodology's scope (third_party: Requesting a meeting with the FDA is a regulatory process step.)
  • uniQure N.V. (QURE): Initiate regulatory interactions to discuss AMT-130 development strategies · outside the methodology's scope (third_party: Initiating regulatory interactions is a collaborative process with a third party (regulator) and is often considered a regulatory event rather than a pure operational commitment.)
  • uniQure N.V. (QURE): Complete comprehensive review of operations · outside the methodology's scope (vague: A 'comprehensive review of operations' is an internal process without a clear, checkable end-product.)
  • uniQure N.V. (QURE): Initiate FDA interaction regarding AMT-130 · outside the methodology's scope (third_party: Interacting with the FDA is a regulatory process dependent on the regulator's availability and engagement.)
  • uniQure N.V. (QURE): Initiate regulatory interactions with the FDA regarding AMT-130 · outside the methodology's scope (third_party: Initiating regulatory interactions is a process involving a third party (FDA).)
  • uniQure N.V. (QURE): Complete the comprehensive review of operations and options to reduce expenses · outside the methodology's scope (vague: A 'comprehensive review of operations' is an internal process/study rather than a specific operational output.)
  • uniQure N.V. (QURE): Complete the review and advice process with the Amsterdam-based works council · outside the methodology's scope (third_party: Completing a works council review is a third-party process.)
  • uniQure N.V. (QURE): Meet with the FDA to discuss expedited clinical development pathways · outside the methodology's scope (third_party: This is a meeting with a regulator (FDA), which is a third-party interaction/review process.)
  • uniQure N.V. (QURE): Conduct a Type B meeting with the FDA regarding AMT-130 · outside the methodology's scope (third_party: Meetings with the FDA are subject to the regulator's schedule and availability.)
  • uniQure N.V. (QURE): Hold a Type B, multi-disciplinary RMAT meeting with the FDA · outside the methodology's scope (third_party: Holding a regulatory meeting is a third-party interaction.)
  • uniQure N.V. (QURE): Complete the organizational restructuring · outside the methodology's scope (vague: Completing an organizational restructuring is a vague corporate process without a specific, checkable operational end point.)
  • uniQure N.V. (QURE): Hold a Type B meeting with the FDA regarding CMC requirements · outside the methodology's scope (third_party: Meetings with the FDA are regulatory interactions/third-party events, not purely internal operational milestones.)
  • uniQure N.V. (QURE): Hold additional sub-disciplinary meetings with the FDA regarding AMT-130 · outside the methodology's scope (third_party: Meetings with the FDA are subject to the regulator's schedule and availability.)
  • uniQure N.V. (QURE): Hold a Type B meeting with the FDA regarding the pivotal statistical analysis plan · outside the methodology's scope (third_party: Meetings with the FDA are regulatory interactions/third-party events.)
  • uniQure N.V. (QURE): Engage with the FDA to discuss the statistical analysis plan and technical CMC requirements · outside the methodology's scope (third_party: Engaging with the FDA to discuss plans is a regulatory interaction/process, not a direct operational output.)
  • uniQure N.V. (QURE): Provide a regulatory update regarding the BLA submission · outside the methodology's scope (vague: Providing a 'regulatory update' is vague and lacks a specific, checkable operational outcome.)
Corrections
  • Bristol Myers Squibb Co.: deadline corrected from 2022-11-16 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Intel Corp.: deadline corrected from 2021-06-30 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

2 Oct 2026

  • 751added
  • 332outcomes recorded
  • 28confirmed
  • 43withdrawn from publication
  • 22corrected
Withdrawn: Depends on a third party, not the company (15), Outside the methodology's scope (13), Too vague to check (12), Financial forecast, not an operational deliverable (2), Accounting or internal process (1)
  • Abeona Therapeutics Inc. (ABEO): Treat the first patient with pz-cel · outside the methodology's scope (third_party: The commitment is conditional on regulatory approval, which is a third-party action.)
  • Adma Biologics, Inc. (ADMA): Present real-world ASCENIV outcomes at the CIS meeting · outside the methodology's scope (event: Presenting at a meeting is a routine corporate event.)
  • Alignment Healthcare, Inc. (ALHC): Invest in new market infrastructure · outside the methodology's scope (vague: Investing in infrastructure is a vague, open-ended plan.)
  • AST SpaceMobile, Inc. (ASTS): Expand manufacturing footprint to over 400,000 square feet · outside the methodology's scope (vague: Expanding a manufacturing footprint is a general operational plan without a specific, checkable end-state action.)
  • Banc Of California, Inc. (BANC): Invest remaining proceeds from securities repositioning · outside the methodology's scope (financial: Investing proceeds is a financial activity rather than an operational one.)
  • Beam Therapeutics Inc. (BEAM): Present BEAM-302 clinical data at ATS 2026 · outside the methodology's scope (event: This is a presentation at a conference/symposium.)
  • Beam Therapeutics Inc. (BEAM): Present updated BEAM-302 data at a medical congress · outside the methodology's scope (event: Presenting data at a medical congress is an event/conference activity.)
  • Beam Therapeutics Inc. (BEAM): File IND application for BEAM-304 · outside the methodology's scope (third_party: Filing an IND is a regulatory submission/action.)
  • Beta Bionics, Inc. (BBNX): Fully commercialize the Mint patch pump · outside the methodology's scope (third_party: Commercialization is explicitly subject to regulatory clearance.)
  • Beta Bionics, Inc. (BBNX): Expand iLet indications for use to adults with type 2 diabetes in the U.S · outside the methodology's scope (third_party: Expanding indications is explicitly subject to FDA regulatory clearance.)
  • Better Home & Finance Holding Co (BETR): Expand HELOC product set beyond direct-to-consumer · outside the methodology's scope (vague: Expanding a product set is an open-ended operational improvement without a clear, checkable end point.)
  • Capricor Therapeutics, Inc. (CAPR): Meet with the U.S. FDA to discuss the Deramiocel BLA · outside the methodology's scope (third_party: Meeting with the FDA is a regulatory interaction/third-party process.)
  • Capricor Therapeutics, Inc. (CAPR): Report initial topline data from the StealthX Phase 1 clinical trial · outside the methodology's scope (third_party: The commitment is contingent on completion by NIAID, a third party.)
  • Capricor Therapeutics, Inc. (CAPR): Complete validation and FDA inspection of the second-floor expansion at the San Diego manufacturing facility · outside the methodology's scope (third_party: The commitment relies on an FDA inspection, which is a third-party action.)
  • Corcept Therapeutics Inc. (CORT): Present results from the MOMENTUM trial at the American College of Cardiology meeting · outside the methodology's scope (event: Presenting at a conference is a routine corporate event.)
  • Corcept Therapeutics Inc. (CORT): Present complete results from the ROSELLA study at the Society of Gynecology Oncology meeting · outside the methodology's scope (event: Presenting at a conference is a routine corporate event.)
  • Disc Medicine, Inc. (IRON): Launch bitopertin in the US · outside the methodology's scope (third_party: The launch is contingent on US regulatory approval.)
  • Disc Medicine, Inc. (IRON): Hold a Type A meeting with the US FDA to review approach for resubmission · outside the methodology's scope (third_party: Attending a meeting with the FDA is a regulatory interaction.)
  • Disc Medicine, Inc. (IRON): Conduct end-of-Phase 2 meeting with the FDA for selcodebart · outside the methodology's scope (third_party: The commitment is to conduct a meeting with the FDA, which is a third-party interaction.)
  • Eos Energy Enterprises, Inc. (EOSE): Ramp sub-assembly automation · outside the methodology's scope (vague: Ramping automation is an ongoing process without a clear, checkable completion point.)
  • Eos Energy Enterprises, Inc. (EOSE): Achieve 4 GWh annual run-rate manufacturing capacity · outside the methodology's scope (vague: Targeting a run-rate capacity is a performance target rather than a specific operational milestone.)
  • Hyliion Holdings Corp. (HYLN): Complete final Power Module certification · outside the methodology's scope (third_party: Certification is a third-party approval process.)
  • Hyliion Holdings Corp. (HYLN): Achieve full 200 kilowatt design power rating · outside the methodology's scope (financial: Achieving a power rating is a performance target.)
  • Hyliion Holdings Corp. (HYLN): Commercialize the KARNO generator platform · outside the methodology's scope (vague: Commercialization is an open-ended process without a specific, checkable end point.)
  • Hyliion Holdings Corp. (HYLN): Accelerate production scale-up and printer purchases · outside the methodology's scope (vague: Accelerating scale-up and purchases is an open-ended operational plan without a specific, checkable end state.)
  • Larimar Therapeutics, Inc. (LRMR): Provide regulatory update and timeline confirmation · outside the methodology's scope (vague: Providing a regulatory update is a vague, open-ended communication plan.)
  • LENZ Therapeutics, Inc. (LENZ): Achieve broad product availability for VIZZ · outside the methodology's scope (vague: Broad product availability is an open-ended goal without a clear, checkable operational definition.)
  • Neogen Corp. (NEOG): Close the sale of the global Genomics business to Zoetis Inc · outside the methodology's scope (third_party: Closing a sale/divestiture is a transaction dependent on the buyer and regulatory approvals.)
  • Our Bond, Inc. (OBAI): Resolve Nasdaq listing compliance matters · outside the methodology's scope (vague: Resolving listing compliance is a vague corporate goal without a specific, checkable operational action.)
  • Perspective Therapeutics, Inc. (CATX): Release clinical data for three independent clinical-stage programs · outside the methodology's scope (already_done: The commitment refers to data in 2026, which is the current year or past, and implies the data release is an ongoing or completed process.)
  • Rackspace Technology, Inc. (RXT): Ramp Enterprise AI business to a cumulative capacity of 15 MW · outside the methodology's scope (vague: Ramping capacity is a performance target/ramp-up plan without a specific operational milestone.)
  • Rackspace Technology, Inc. (RXT): Ramp Enterprise AI business to a cumulative capacity of 30 MW · outside the methodology's scope (vague: Ramping capacity is a performance target/ramp-up plan without a specific operational milestone.)
  • Replimune Group, Inc. (REPL): Present clinical data for RP1 plus nivolumab at the SITC 2025 meeting · outside the methodology's scope (event: This is a presentation at a conference.)
  • Replimune Group, Inc. (REPL): Present data on retreatment with RP1 plus nivolumab at the SITC 2025 meeting · outside the methodology's scope (event: This is a presentation at a conference.)
  • SELLAS Life Sciences Group, Inc. (SLS): Present preclinical data on SLS009 at ASCO 2025 · outside the methodology's scope (event: Presenting at a conference is a routine corporate event.)
  • SELLAS Life Sciences Group, Inc. (SLS): Present preclinical data on SLS009 in T-PLL at the ESMO congress · outside the methodology's scope (event: Presenting at a conference is a routine corporate event.)
  • SELLAS Life Sciences Group, Inc. (SLS): Present preclinical data on SLS009 at the 2026 AACR meeting · outside the methodology's scope (event: Presenting at a conference is a routine corporate event.)
  • T-Mobile US, Inc. (TMUS): Maintain rate plans for three years · outside the methodology's scope under the current rules
  • uniQure N.V. (QURE): Present initial safety and efficacy data for AMT-260 · outside the methodology's scope (event: Presenting data at a symposium is a routine corporate event.)
  • uniQure N.V. (QURE): Hold pre-BLA meeting with the FDA · outside the methodology's scope (third_party: Meeting with the FDA is a collaborative regulatory event.)
  • uniQure N.V. (QURE): Request a follow-up meeting with the FDA · outside the methodology's scope (third_party: Requesting a meeting with the FDA is a regulatory interaction/process.)
  • uniQure N.V. (QURE): Complete the four-year analysis of AMT-130 data · outside the methodology's scope (accounting: Statistical analysis of data is an internal analytical/reporting process, not an operational delivery.)
  • uniQure N.V. (QURE): Launch AMT-130 in the U.S · outside the methodology's scope (third_party: The launch is explicitly contingent on regulatory approval, making it a third-party dependency.)
Corrections
  • AbbVie Inc.: deadline corrected from 2020-06-30 to 2020-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Acadia Pharmaceuticals Inc.: deadline corrected from 2024-03-31 to 2024-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Amazon COM Inc.: deadline corrected from 2021-10-29 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Beam Therapeutics Inc.: deadline corrected from 2024-12-31 to 2023-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Corcept Therapeutics Inc.: deadline corrected from 2026-06-30 to 2026-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Corcept Therapeutics Inc.: deadline corrected from 2026-03-31 to 2026-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Emergent BioSolutions Inc.: deadline corrected from 2023-09-30 to 2023-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Hyliion Holdings Corp.: deadline corrected from 2023-09-30 to 2023-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Larimar Therapeutics, Inc.: deadline corrected from 2022-06-30 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Lincoln Educational Services Corp.: deadline corrected from 2027-03-31 to 2027-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Mcdonalds Corp.: deadline corrected from 2021-03-31 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • SELLAS Life Sciences Group, Inc.: deadline corrected from 2022-06-30 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • SELLAS Life Sciences Group, Inc.: deadline corrected from 2023-06-30 to 2023-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • SELLAS Life Sciences Group, Inc.: deadline corrected from 2023-03-31 to 2023-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • SELLAS Life Sciences Group, Inc.: deadline corrected from 2024-01-31 to 2024-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Unicycive Therapeutics, Inc.: deadline corrected from 2022-06-30 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Unicycive Therapeutics, Inc.: deadline corrected from 2024-09-30 to 2024-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • uniQure N.V.: deadline corrected from 2022-06-30 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • uniQure N.V.: deadline corrected from 2022-09-30 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • uniQure N.V.: deadline corrected from 2022-06-30 to 2022-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Wells Fargo & Company: deadline corrected from 2021-03-31 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Wells Fargo & Company: deadline corrected from 2021-03-31 to 2021-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

1 Oct 2026

  • 985added
  • 479outcomes recorded
  • 42confirmed
  • 40withdrawn from publication
  • 4corrected
Withdrawn: Financial forecast, not an operational deliverable (18), Too vague to check (9), Depends on a third party, not the company (7), Outside the methodology's scope (4), Accounting or internal process (2)
  • AbbVie Inc. (ABBV): Begin Mylan's U.S. license for biosimilar adalimumab · outside the methodology's scope (third_party: This is a license agreement involving another company (Mylan), not an internal operational commitment by AbbVie.)
  • AEON Biopharma, Inc. (AEON): Return to the FDA with an integrated evidence package · outside the methodology's scope (vague: Returning to the FDA with an 'integrated evidence package' is a vague, non-specific operational milestone.)
  • Amazon COM Inc. (AMZN): Increase hourly minimum wage for U.S. and U.K. employees · outside the methodology's scope (financial: This is a wage/compensation change, which is a financial/HR policy matter rather than an operational milestone.)
  • Amazon COM Inc. (AMZN): Commit research grants for AI fairness · outside the methodology's scope (vague: Committing research grants is a financial allocation rather than a specific operational milestone.)
  • Bassett Furniture Industries Inc. (BSET): Debut a new 44,000-square-foot showroom at the High Point Market · outside the methodology's scope (event: Debuting a showroom at a trade show is a routine corporate event/exhibition.)
  • Bristol Myers Squibb Co. (BMY): Extend the expiration date for exchange offers for Celgene Corporation notes · outside the methodology's scope (accounting: This is a routine corporate/financial administrative action related to debt/notes.)
  • Cal-Maine Foods Inc. (CALM): Increase Prepared Foods production capacity by more than 60% · outside the methodology's scope (vague: Increasing capacity is a general operational plan without a specific, checkable end-point action.)
  • Coca Cola Co. (KO): Ensure 70% of all PET bottles in the Australian market are made from 100% rPET · outside the methodology's scope (financial: This is a target for percentage of materials used, which functions as a performance/sustainability metric rather than a discrete operational event.)
  • Conocophillips (COP): Execute turnarounds and maintenance activity · outside the methodology's scope (vague: Routine maintenance activity is not a specific, checkable operational milestone.)
  • Dick'S Sporting Goods, Inc. (DKS): Include Foot Locker in the quarterly comparable store base · outside the methodology's scope (financial: This relates to the methodology for calculating comparable store base, which is a financial reporting metric.)
  • Dick'S Sporting Goods, Inc. (DKS): Include Foot Locker in quarterly comparable sales calculations · outside the methodology's scope (financial: This relates to the methodology for calculating comparable sales, which is a financial reporting metric.)
  • Duke Energy Corp. (DUK): Implement new retail rates · outside the methodology's scope (third_party: The commitment is contingent on a regulatory approval (NCUC), making it a third-party dependency.)
  • Fedex Corp. (FDX): Execute voluntary buyout program for U.S.-based employees · outside the methodology's scope (financial: This is a financial charge/cost estimate, not an operational milestone.)
  • Fluence Energy, Inc. (FLNC): Increase utilization of the India Technology Centre · outside the methodology's scope (vague: Increasing utilization is an open-ended operational goal without a specific, checkable end point.)
  • Fluence Energy, Inc. (FLNC): Reach targeted capacity at U.S. manufacturing facilities · outside the methodology's scope (vague: Reaching 'targeted capacity' is a performance target rather than a specific operational milestone.)
  • Fluence Energy, Inc. (FLNC): Receive first order from hyperscalers · outside the methodology's scope (third_party: Receiving an order is dependent on the customer's action, not the company's own operational output.)
  • Gilead Sciences Inc. (GILD): Seek regulatory approval for filgotinib in the United States and Europe · outside the methodology's scope (third_party: Seeking regulatory approval is dependent on third-party action.)
  • Lilly ELI & Co. (LLY): Present detailed Verzenio clinical trial data at a medical meeting · outside the methodology's scope (event: Presenting data at a medical meeting is a routine corporate/industry event.)
  • Lilly ELI & Co. (LLY): Submit Trulicity data to regulatory authorities · outside the methodology's scope (third_party: Submitting data to regulatory authorities is a step toward a third-party approval process.)
  • Lilly ELI & Co. (LLY): Submit a U.S. regulatory filing for tanezumab · outside the methodology's scope (third_party: Submitting a regulatory filing is a step toward a third-party approval process.)
  • Liquidia Corp (LQDA): Submit a form of judgment to the District Court · outside the methodology's scope (third_party: Submitting a form of judgment to a court is a legal/regulatory process involving a third party.)
  • Lockheed Martin Corp. (LMT): Complete the annual remeasurement of postretirement benefit plans · outside the methodology's scope (accounting: Remeasuring benefit plans is an accounting/actuarial task.)
  • Merck & Co., Inc. (MRK): Present additional oncology program data at the SITC 2018 meeting · outside the methodology's scope (event: This is a commitment to present at a conference/meeting.)
  • Merck & Co., Inc. (MRK): Present Phase 3 KEYNOTE-426 trial data at the ASCO Genitourinary Cancers Symposium · outside the methodology's scope (event: Presenting data at a conference is a routine corporate event.)
  • Nvidia Corp. (NVDA): Record a GAAP discrete tax benefit related to U.S. tax reform transition tax · outside the methodology's scope (accounting: Recording a tax benefit is an accounting/financial reporting action, not an operational commitment.)
  • Pentair plc (PNR): Move to three reporting segments: Pool, Water Solutions, and Industrial & Flow Technologies · outside the methodology's scope (accounting: Changing reporting segments is an accounting/organizational structure change, not an operational commitment.)
  • Pinnacle West Capital Corp. (PNW): Complete proposed transmission for new gas · outside the methodology's scope (vague: The commitment is 'TBD' and lacks a specific, checkable operational definition.)
  • Starbucks Corp. (SBUX): Open approximately 300 net new stores in the EMEA region · outside the methodology's scope (financial: This is a target for store count growth, which is a performance/financial metric.)
  • T-Mobile US, Inc. (TMUS): Achieve nationwide 5G coverage · outside the methodology's scope (vague: Achieving nationwide coverage is a broad, non-specific operational goal without a clear, checkable milestone.)
  • T-Mobile US, Inc. (TMUS): Deploy nationwide 5G coverage · outside the methodology's scope (vague: Deploying nationwide coverage is a broad, non-specific operational goal without a clear, checkable milestone.)
  • Tesla, Inc. (TSLA): Increase MWh deployed for energy storage products by three-fold · outside the methodology's scope (financial: This is a performance/growth target (increasing MWh deployed by three-fold).)
  • Tesla, Inc. (TSLA): Ramp Solar Roof production · outside the methodology's scope (vague: Ramping production 'toward the end of 2018' is too vague to be a checkable operational milestone.)
  • Verizon Communications Inc. (VZ): Expand commercial launch of 5G · outside the methodology's scope (financial: The commitment is framed as part of a capital spending budget/forecast rather than a specific operational milestone.)
  • Walmart Inc. (WMT): Reach approximately 3,100 grocery pickup and 1,600 grocery delivery locations · outside the methodology's scope (financial: This is a target for the number of locations, which functions as a performance/growth metric.)
  • Walmart Inc. (WMT): Complete the full scheme buy-out of the Asda Group Pension Scheme · outside the methodology's scope (accounting: A pension scheme buy-out is an accounting/financial transaction.)
  • Walt Disney Co (DIS): Complete the early settlement of validly tendered notes · outside the methodology's scope (accounting: This is a routine financial/accounting settlement of notes.)
  • Walt Disney Co (DIS): Complete early settlement of tender offers · outside the methodology's scope (accounting: This is a routine financial/accounting settlement of tender offers.)
  • Walt Disney Co (DIS): Expire the tender offers for notes · outside the methodology's scope (accounting: This is a routine financial/accounting expiration of tender offers.)
  • Walt Disney Co (DIS): Complete final settlement of tender offers · outside the methodology's scope (accounting: This is a routine financial/accounting settlement of tender offers.)
  • Walt Disney Co (DIS): Complete the final settlement of tendered notes · outside the methodology's scope (accounting: This is a routine financial/accounting settlement of notes.)
Corrections
  • Fluence Energy, Inc.: deadline corrected from 2024-09-22 to 2024-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • General Motors Co: deadline corrected from 2020-03-31 to 2020-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Palo Alto Networks Inc: deadline corrected from 2019-06-30 to 2019-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Tesla, Inc.: deadline corrected from 2019-03-31 to 2019-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date

30 Sep 2026

  • 247added
  • 99outcomes recorded
  • 35confirmed
  • 47withdrawn from publication
  • 6corrected
Withdrawn: Too vague to check (18), Depends on a third party, not the company (13), Outside the methodology's scope (10), Financial forecast, not an operational deliverable (4), Accounting or internal process (2)
  • Acelyrin, Inc.: Deliver Phase 3 topline data for ESK-001 in moderate-to-severe plaque psoriasis · reviewed by a person: outside the methodology's scope
  • Adma Biologics, Inc. (ADMA): Commence pre-clinical development for the S. pneumonia hyperimmune pipeline program · reviewed by a person: outside the methodology's scope
  • AEON Biopharma, Inc. (AEON): Hold Biosimilar Biological Product Development Type 2 meeting to discuss comparative analytical studies · outside the methodology's scope (third_party: A regulatory meeting is a third-party interaction/approval process.)
  • Aldeyra Therapeutics, Inc. (ALDX): Hold a meeting with the FDA Office of New Drugs regarding the FDRR · outside the methodology's scope (third_party: The commitment involves a meeting with a regulator.)
  • Aldeyra Therapeutics, Inc. (ALDX): Submit a Formal Dispute Resolution Request and meet with the Office of New Drugs · outside the methodology's scope (third_party: The commitment relies on a meeting with a regulator (Office of New Drugs), which is a third-party interaction.)
  • Aldeyra Therapeutics, Inc. (ALDX): Submit a Formal Dispute Resolution Request for reproxalap to the FDA · outside the methodology's scope (third_party: The commitment involves a regulatory submission and meeting with a regulator.)
  • Amarin Corp. plc (AMRN): Resubmit pricing and reimbursement applications in Europe · outside the methodology's scope (third_party: Resubmitting applications for pricing and reimbursement is dependent on regulatory/government bodies.)
  • Amarin Corp. plc (AMRN): Submit strengthened clinical assessments for European pricing and reimbursement · outside the methodology's scope (third_party: Submitting assessments for pricing and reimbursement is dependent on regulatory/government bodies.)
  • American Rebel Holdings Inc. (AREB): Run American Rebel Light Beer Scan to Win promotion at Tennessee retail locations · outside the methodology's scope (event: This is a marketing promotion/event.)
  • AmpliTech Group, Inc. (AMPG): Obtain all FCC certifications and licenses for Gigspeed AmpliTech private 5G services · outside the methodology's scope (third_party: Obtaining FCC certifications is a regulatory approval process.)
  • Anaptysbio, Inc. (ANAB): Prepare BLA and MAA applications for imsidolimab in US and EU · outside the methodology's scope (vague: Preparing applications is a process, not a specific, checkable end-point event.)
  • Ball Corp (BALL): Form strategic partnership for aluminum cup business · outside the methodology's scope (vague: The commitment to 'form a strategic partnership' is vague and lacks a specific, checkable operational outcome.)
  • Black Hills Corp. (BKH): Request certificate of public convenience and necessity in Wyoming for natural gas resources · outside the methodology's scope (third_party: Requesting a certificate is a regulatory filing step that depends on third-party approval.)
  • Caribou Biosciences, Inc. (CRBU): Disclose multiple clinical datasets across four programs · outside the methodology's scope (vague: Disclosing 'multiple datasets' is too vague and lacks a specific, checkable end point.)
  • CNS Pharmaceuticals, Inc. (CNSP): Meet with FDA to discuss berubicin program based on primary analysis · outside the methodology's scope (third_party: Meeting with the FDA is a regulatory interaction/process, not a unilateral operational commitment.)
  • Cummins Inc. (CMI): Start production at Amplify Cell Technologies battery factory in Marshall County, Mississippi · outside the methodology's scope (vague: The provided text mentions construction began but does not state a specific start date for production, only implying a future timeline.)
  • Evans Bancorp Inc.: Close the merger with NBT Bancorp Inc · outside the methodology's scope (being_acquired: The company is being acquired; this is a merger event.)
  • Generation Bio Co.: Enter clinical development within cash runway · outside the methodology's scope (vague: Entering the clinic 'within cash runway' is a vague, non-specific timeline.)
  • HOOKIPA Pharma Inc.: Complete HB-400 Phase 1b trial primary completion · outside the methodology's scope (third_party: The trial is Gilead-led, making it a third-party program.)
  • Inari Medical, Inc.: Close acquisition of Inari Medical, Inc · outside the methodology's scope (being_acquired: The company is the subject of the acquisition, not the acquirer.)
  • MID America Apartment Communities Inc. (MAA-PI): Stabilize two lease-up communities · outside the methodology's scope (financial: Lease-up stabilization is a financial/performance metric, not a specific operational event.)
  • MID America Apartment Communities Inc. (MAA-PI): Stabilize one lease-up community · outside the methodology's scope (financial: Lease-up stabilization is a financial/performance metric, not a specific operational event.)
  • Molina Healthcare, Inc. (MOH): Commence implementation of recent Medicaid and Medicare Duals contract wins · reviewed by a person: outside the methodology's scope
  • New Fortress Energy Inc. (NFE): Achieve PortoCem turbine commercial operation dates · reviewed by a person: outside the methodology's scope
  • New Fortress Energy Inc. (NFE): Start third-party gas supply contract operations · reviewed by a person: outside the methodology's scope
  • New Jersey Resources Corp. (NJR): Operate the SAVEGREEN energy efficiency program through June 2027 · outside the methodology's scope (vague: Operating an ongoing program is a routine business activity, not a specific, checkable end-point event.)
  • NuStar Energy L.P.: Close the acquisition of NuStar Energy L.P · outside the methodology's scope (being_acquired: The company is the one being acquired, so this belongs to the buyer's record.)
  • OS Therapies Inc (OSTX): Deliver clinical data and BLA-enabling requirements for OST-HER2 FDA authorization · outside the methodology's scope (third_party: The commitment is contingent on receiving FDA authorization, which is a third-party regulatory action.)
  • Premier, Inc.: Address greater than 75% of August 2020 restructure GPO member fees · outside the methodology's scope (financial: This relates to the resolution of financial liabilities or fee structures rather than a core operational milestone.)
  • reAlpha Tech Corp. (AIRE): Provide further updates and announcements regarding blockchain and digital assets integration · outside the methodology's scope (vague: Providing updates and announcements is a corporate communication activity, not a specific operational milestone.)
  • Roblox Corp (RBLX): Develop 3D Foundational Model and AI creation tools · outside the methodology's scope (vague: Developing AI tools is a broad, ongoing development effort without a specific, checkable completion point.)
  • Roblox Corp (RBLX): Launch new safety products and policies on the platform · outside the methodology's scope (vague: Launching 'many more' safety products is a broad, non-specific plan.)
  • Silo Pharma, Inc. (SILO): Begin Phase 1 clinical trial of intranasal SPC-15 in PTSD · outside the methodology's scope (third_party: The commitment is explicitly conditional on regulatory approval (IND approval).)
  • Silver Star Properties Reit, Inc.: Complete catch-up audits for 2023 and 2024 to become fully reporting company · outside the methodology's scope (accounting: This is an accounting/reporting task.)
  • Southern Co. (SOMN): Finalize gain/loss calculations for Southern Company Gas dispositions · outside the methodology's scope (accounting: Finalizing gain/loss calculations is an accounting/financial reporting task.)
  • Southern Co. (SOMN): Complete 2017 federal income tax return and actualize provisional estimates · outside the methodology's scope (accounting: Completing tax returns and actualizing estimates are accounting tasks.)
  • Sun Country Airlines Holdings, Inc.: Complete ratification vote on flight attendants and dispatchers collective bargaining agreements · outside the methodology's scope (third_party: A ratification vote depends on the actions of the union members, not just the company.)
  • Tessera Defense & Homeland Security Inc. (HLSQ): Complete 15 expansion projects with existing customers · outside the methodology's scope (vague: This is a performance target (number of projects) rather than a specific operational milestone.)
  • Tessera Defense & Homeland Security Inc. (HLSQ): Establish 16 new or expanded integrator and channel relationships · outside the methodology's scope (vague: Establishing channel relationships is a business development goal lacking a specific, checkable operational endpoint.)
  • Tessera Defense & Homeland Security Inc. (HLSQ): Integrate 5 additional platform capabilities · outside the methodology's scope (vague: Integrating platform capabilities is a broad development goal rather than a specific, checkable operational milestone.)
  • Tessera Defense & Homeland Security Inc. (HLSQ): Acquire 60 new customers · outside the methodology's scope (vague: This is a performance target (number of customers) rather than a specific operational milestone.)
  • Tessera Defense & Homeland Security Inc. (HLSQ): Enter 3 new geographies · outside the methodology's scope (vague: This is a performance target (number of geographies) rather than a specific operational milestone.)
  • Tessera Defense & Homeland Security Inc. (HLSQ): Achieve 70 Tessera platform deployments · outside the methodology's scope (vague: These are performance targets (number of deployments) rather than specific operational milestones.)
  • Tessera Defense & Homeland Security Inc. (HLSQ): Expand into 2 new verticals · outside the methodology's scope (vague: Expanding into verticals is a strategic goal rather than a specific, checkable operational milestone.)
  • Universal Technical Institute Inc. (UTI): Open new campuses beginning in fiscal 2026 · outside the methodology's scope (vague: The commitment to open campuses is open-ended and lacks a specific, checkable end point or count.)
  • Virginia Electric & Power Co.: Commence wind turbine blade fabrication · outside the methodology's scope (already_done: The text states fabrication commenced in Feb 2025, which is the current month/past.)
  • Volato Group, Inc. (SOAR): Add new aircraft to the fleet · outside the methodology's scope (vague: Adding new aircraft is a general operational plan without a specific, checkable end point or quantity.)
Corrections
  • Altria Group, Inc.: deadline corrected from 2018-06-30 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Boeing Co.: deadline corrected from 2018-10-31 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Honeywell International Inc.: deadline corrected from 2026-06-30 to 2026-03-31 · 'by the end of 2025 or early in 2026' ends with early 2026, which is 31 March under the published rules
  • Intuit Inc.: deadline corrected from 2018-07-31 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Nextera Energy Inc.: deadline corrected from 2018-09-30 to 2018-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Pinnacle West Capital Corp.: commitment reworded (was: Complete deployment of advanced meters) · full meter deployment finished in 2014; the stated Q1 2015 - Q2 2016 programme replaces end-of-life meters

29 Sep 2026

  • 326added
  • 146outcomes recorded
  • 44confirmed
  • 57withdrawn from publication
  • 15corrected
Withdrawn: Financial forecast, not an operational deliverable (19), Too vague to check (17), Outside the methodology's scope (10), Depends on a third party, not the company (9), Accounting or internal process (2)
  • 60 Degrees Pharmaceuticals, Inc. (SXTP): Complete interim analysis of tafenoquine babesiosis treatment study · outside the methodology's scope (accounting: Interim analysis is an internal data review step, not a public operational milestone like a trial completion or filing.)
  • Acelyrin, Inc.: Close the merger of Alumis and ACELYRIN · outside the methodology's scope (being_acquired: The company is merging/being acquired; this is a corporate transaction event.)
  • Air Transport Services Group, Inc.: Close the acquisition by Stonepeak · outside the methodology's scope (being_acquired: The company is the one being acquired.)
  • Alumis Inc. (ALMS): Close the merger of Alumis and ACELYRIN · outside the methodology's scope (being_acquired: The company is the one being acquired/merging.)
  • ARK Restaurants Corp. (ARKR): Distribute approximately 35% of net proceeds to other equity holders of Ark Hollywood/Tampa Investment LLC · outside the methodology's scope (financial: This is a financial distribution of proceeds to equity holders, which is a capital allocation event rather than an operational commitment.)
  • Artificial Intelligence Technology Solutions Inc. (AITX): Achieve $200,000 in monthly cash SG&A spending reductions · outside the methodology's scope (financial: This is a cost-cutting/financial savings target.)
  • Artificial Intelligence Technology Solutions Inc. (AITX): Substantially implement remaining cost reduction plan actions · outside the methodology's scope (vague: Implementing 'remaining actions' of a plan is too vague to be a checkable operational milestone.)
  • Cactus, Inc. (WHD): Deliver approximately $110 million in awarded Latin America orders · outside the methodology's scope (financial: This is a delivery of orders, which functions as a revenue/sales target.)
  • Cipher Digital Inc. (CIFR): Commence rent for the first data hall at the Barber Lake site · outside the methodology's scope (financial: Rent commencement is a financial/contractual milestone rather than an operational activity.)
  • Citius Oncology, Inc. (CTOR): Make permanent J-code J9161 effective for LYMPHIR billing and reimbursement · outside the methodology's scope (third_party: The effectiveness of a J-code is determined by a third-party regulatory/reimbursement body, not the company's own operational action.)
  • Citius Pharmaceuticals, Inc. (CTXR): Make permanent J-code J9161 effective for LYMPHIR billing and reimbursement · outside the methodology's scope (third_party: This is a regulatory/administrative effective date for a code, not an operational action by the company.)
  • Cleanspark, Inc. (CLSK): Achieve 50 EH/s operating hashrate capacity · outside the methodology's scope (financial: This is a performance/capacity target (hashrate).)
  • CMS Energy Corp. (CMS): Receive order on Renewable Energy Plan U-21816 · outside the methodology's scope (third_party: This is a regulatory order/decision by a commission, not an operational action by the company.)
  • CompoSecure, Inc. (GPGI): Distribute shares of Resolute Holdings Management Inc. to CompoSecure shareholders · outside the methodology's scope (financial: This is a corporate action involving the distribution of shares/capital, not an operational commitment.)
  • Dakota Gold Corp. (DC): Begin drilling to expand Richmond Hill resource in permitted areas · outside the methodology's scope (vague: Goal is dependent on permitting and lacks a firm commitment to start.)
  • ELI Lilly & Co (LLY): Produce at least 1.6 times the amount of salable incretin doses in first half of 2025 · outside the methodology's scope (financial: This is a production volume target, which is a performance/operational output metric rather than a specific project milestone.)
  • Embecta Corp. (EMBC): Launch brand transition plan in U.S. and Canada · outside the methodology's scope (vague: A 'brand transition plan' is an internal corporate initiative without a clear, checkable end-state or specific operational deliverable.)
  • enGene Therapeutics Inc. (ENGN): Conduct pre-Biologics License Application meeting with the FDA · outside the methodology's scope (third_party: This is a meeting with the FDA, which is a regulatory interaction/review process.)
  • EVI Industries, Inc. (EVI): Deploy field service technology to additional service organization portions · outside the methodology's scope (vague: Continued deployment is an ongoing process without a defined, checkable end point.)
  • Flotek Industries Inc. (FTK): Achieve active deployment on over 50% of domestic natural gas fleets by year end · outside the methodology's scope (financial: Achieving a percentage of market share or fleet penetration is a financial/performance target.)
  • Flotek Industries Inc. (FTK): Establish extended supply operation to support activity throughout mid-2027 · outside the methodology's scope (vague: Establishing an operation to support activity is an ongoing business process, not a discrete milestone.)
  • Gain Therapeutics, Inc. (GANX): Begin Phase 2 planning for GT-02287 · outside the methodology's scope (vague: Planning is a preparatory, non-specific activity without a clear, checkable end point.)
  • GRI Bio, Inc. (GRI): Advance GRI-0803 program in H1 2027 · outside the methodology's scope (vague: Advancing a program is too vague and lacks a specific, checkable end point.)
  • GrowGeneration Corp. (GRWG): Increase proprietary brand sales to 35% of Cultivation and Gardening net sales · outside the methodology's scope (financial: This is a financial/performance target (percentage of sales).)
  • Honeywell International Inc. (HON): Complete sale of Personal Protective Equipment business · outside the methodology's scope (assumption: Stated as a guidance assumption rather than a firm commitment.)
  • Inhibrx Biosciences, Inc. (INBX): Meet with FDA to discuss 1L CRC registrational trial design · outside the methodology's scope (third_party: Meeting with the FDA is a regulatory interaction/process, not a direct operational output.)
  • Inhibrx Biosciences, Inc. (INBX): Launch ozekibart for metastatic or unresectable chondrosarcoma · outside the methodology's scope (third_party: Commercial launch is contingent upon regulatory approval, which is a third-party action.)
  • Integra Lifesciences Holdings Corp. (IART): Complete all FDA warning letter commitments · outside the methodology's scope (third_party: Completing warning letter commitments is tied to regulatory approval/satisfaction.)
  • iQSTEL Inc (IQST): Achieve 500,000 gross paying subscriptions · outside the methodology's scope (financial: This is a subscriber count target, which is a financial/performance metric.)
  • iQSTEL Inc (IQST): Reach 500,000 gross subscribers for IDILIO TV service · outside the methodology's scope (financial: Subscriber counts are a performance/growth target.)
  • Kellanova: Close the acquisition by Mars, Incorporated · outside the methodology's scope (being_acquired: The company is the one being acquired.)
  • Latch, Inc. (LTCH): Complete outstanding SEC filings for the year ended December 31, 2023 · outside the methodology's scope (accounting: Completing SEC filings is an accounting/regulatory compliance task.)
  • MID America Apartment Communities Inc. (MAA-PI): Stabilize MAA Breakwater 2 in Tampa with 495 units · outside the methodology's scope (financial: Stabilization is a financial/occupancy performance target.)
  • MID America Apartment Communities Inc. (MAA-PI): Stabilize MAA Val Vista in Phoenix with 317 units · outside the methodology's scope (financial: Stabilization is a financial/occupancy performance target.)
  • MID America Apartment Communities Inc. (MAA-PI): Stabilize MAA Nixie 2 in Raleigh/Durham with 406 units · outside the methodology's scope (financial: Stabilization is a financial/occupancy performance target.)
  • MID America Apartment Communities Inc. (MAA-PI): Stabilize MAA Liberty Row in Charlotte with 239 units · outside the methodology's scope (financial: Stabilization is a financial/occupancy performance target.)
  • Monolithic Power Systems Inc. (MPWR): Ramp new high accuracy 24-bit analog to digital converters · outside the methodology's scope (vague: Ramping is an open-ended process without a defined completion point.)
  • NN Inc. (NNBR): Complete significant new awards and ramps in Defense and Electronics segment · outside the methodology's scope (vague: New awards and ramps are general business activities without a clear, checkable end point.)
  • NN Inc. (NNBR): Ramp production of robotic-assisted surgery equipment components · outside the methodology's scope (vague: Ramping production is a continuous process, not a discrete operational milestone.)
  • Ocugen, Inc. (OCGN): Initiate Phase 3 trial for OCU410 (geographic atrophy) · outside the methodology's scope (already_done: The company words state the trial was already initiated.)
  • Patterson UTI Energy Inc. (PTEN): Surpass 200,000 horsepower of natural gas-powered Emerald completion equipment · outside the methodology's scope (financial: Surpassing a capacity metric (horsepower) is a performance/capacity target rather than a specific project completion.)
  • Peabody Energy Corp. (BTU): Achieve full run rate production at Centurion longwall operation · outside the methodology's scope (vague: Achieving a 'full run rate' is a performance/production target rather than a discrete operational event.)
  • Perspective Therapeutics, Inc. (CATX): Present patient exposure and follow-up data for VMT-α-NET in ASCO 2026 data analysis · outside the methodology's scope (event: Presenting data at a conference is a routine corporate event.)
  • PMGC Holdings Inc. (ELAB): Recruit team members for NorthStrive Biosciences · outside the methodology's scope (vague: Recruiting team members is an ongoing, open-ended operational activity without a specific, checkable end point.)
  • PMGC Holdings Inc. (ELAB): Expand NorthStrive Biosciences pipeline · outside the methodology's scope (vague: Expanding a pipeline is an open-ended strategic goal without a defined, checkable end point.)
  • Post Holdings, Inc. (POST): Complete Post Consumer Brands network optimization and pet food safety and capacity investments · outside the methodology's scope (vague: Describes general investment/expenditure rather than a specific operational milestone.)
  • Pyxis Oncology, Inc. (PYXS): Complete End of Phase 2 FDA meeting to align on MICVO dose selection · outside the methodology's scope (third_party: This is a meeting with the FDA, which is a regulatory interaction.)
  • ServiceTitan, Inc. (TTAN): End fiscal year with over 700 enrolled Max locations · outside the methodology's scope (financial: This is a target for the number of enrolled locations, which is a performance/business metric.)
  • Spectrum Brands Holdings, Inc. (SPB): Complete S/4Hana ERP implementation in Home & Garden business · outside the methodology's scope (already_done: The phrasing implies the go-live has already occurred or is currently occurring in the quarter.)
  • SUNation Energy, Inc. (SUNE): Achieve full ramp of Laurens County solar cell manufacturing facility production capacity · outside the methodology's scope (vague: A 'full ramp' is an open-ended operational improvement without a clear, checkable end point.)
  • Tamboran Resources Corp (TBN): Make an investment decision on the Sturt Plateau Compression Facility expansion · outside the methodology's scope (vague: Making an investment decision is a management/financial planning step, not an operational execution.)
  • Tapestry, Inc. (TPR): Report Fiscal 2025 third quarter results · outside the methodology's scope (event: Routine corporate reporting event.)
  • Tenax Therapeutics, Inc. (TENX): Publish additional LEVEL trial publications · outside the methodology's scope (vague: Publishing 'additional publications' is too open-ended and lacks a specific, checkable deliverable.)
  • Triumph Group Inc.: Close the acquisition by affiliates of Warburg Pincus and Berkshire Partners · outside the methodology's scope (being_acquired: The company is the one being acquired.)
  • Veru Inc. (VERU): Conduct preIND meeting with FDA regarding Phase 2b sabizabulin trial · outside the methodology's scope (third_party: A preIND meeting is a regulatory interaction/process.)
  • Viasat Inc. (VSAT): Achieve return to growth in maritime business line · outside the methodology's scope (financial: Return to growth is a financial/performance target, not a specific operational milestone.)
  • Xeris Biopharma Holdings, Inc. (XERS): Complete Touchstone study in time for NDA submission · outside the methodology's scope (vague: The commitment is vague regarding the actual completion date, referencing an external event (approval) rather than a specific company action date.)
Corrections
  • Coronado Global Resources Inc.: deadline corrected from 2024-06-30 to 2024-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Darden Restaurants Inc.: deadline corrected from 2027-05-30 to 2027-05-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Formfactor Inc.: deadline corrected from 2025-03-29 to 2025-03-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Medtronic plc: deadline corrected from 2017-11-30 to 2018-04-30 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Nvidia Corp.: deadline corrected from 2018-01-31 to 2017-12-31 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Peabody Energy Corp.: deadline corrected from 2025-03-31 to 2025-06-30 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Powell Industries Inc.: deadline corrected from 2025-03-31 to 2025-09-30 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Powell Industries Inc.: outcome changed from late to kept · Powell said the Houston Electrical Products expansion was 'nearing completion' as of March 31, 2025, then confirmed completion and occupancy permits on the May 7, 2025 earnings call.
  • Premier, Inc.: deadline corrected from 2025-12-31 to 2025-06-30 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Rave Restaurant Group, Inc.: deadline corrected from 2027-06-26 to 2027-06-30 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Starbucks Corp.: deadline corrected from 2017-10-01 to 2017-09-30 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Tyco International plc: deadline corrected from 2016-10-01 to 2017-09-30 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Tyco International plc: outcome changed from late to kept · The company completed the Adient spin-off on October 31, 2016, which occurred shortly after the beginning of the fiscal year.
  • Unifi Inc.: deadline corrected from 2025-03-31 to 2025-04-30 · the stated period ends on this date under the company's fiscal calendar or the statement date
  • Universal Technical Institute Inc.: deadline corrected from 2026-06-30 to 2026-09-30 · the stated period ends on this date under the company's fiscal calendar or the statement date

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.